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CHAPTER I 
INTRODUCTION 
A. DEVELOPMENT OF MONOCLONAL TECHNOLOGY 
When the immune system responds to a foreign antigen, the 
antibodies which are generated, bind to a variety of epitopes in that 
antigen. Each B cell recruited by the immune system produces a single 
antibody which is directed towards only one of a whole group of 
epitopes which as a whole make up the antigen. Monoclonal antibody 
production is a powerful tool which enables the formation of large 
amounts of a single antibody. This technique allows the selection of 
a single B cell, its expansion by fusion with an immortal cell line, 
followed by isolation of the desired clone, and thus the generation of 
large quantities of the B cell specific antibody. 
Much of the early work on cloning, was carried out by Kohler and 
Milstein (1975). These investigators fused the myeloma cell P3-X63-
Ag8 (a cell line which was derived from Balb/c mice) with spleen cells 
from Balb/c mice immunized with sheep red blood cells (SRBC). The 
fusion of these cells was accomplished through the use of an 
inactivated Sendi virus. This was an important step since the single 
antibody that was produced was directed against a preselected antigen 
( ie. SRBC). In addition different cell lines could be made against 
the various epitopes that were part of the antigen. In later 
1 
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experiments designed to determine the rate of spontaneous loss of 
immunoglobulin secretion, Kohle et al., (1976) isolated nonsecreting 
plasmacytomas. 
production. 
These immortal cells could then be used for hybrid 
By putting hybrids back into a mouse of the same haplotype 
(Balb/c) solid tumors could be generated. The tumor would continue to 
produce the monoclonal antibody as long as the mouse survived the 
tumor. In addition, not only were all nutrient requirements of the 
cell line met by the host animal, but also the tumor was maintained in 
an environment free from the cells own waist products and from 
contamination by bacteria,molds and fungi. 
B. STREPTOCOCCAL SEQUELAE 
Since the early 194O's an association between Group A, strepto-
coccal infection and acute glomerulonephritis (AGN) was suggested 
(Futcher,194O). Despite many attempts to elucidate the connection 
between these two disease states, the pathogenic mechanisms which lead 
to post streptococcal sequelae are still unclear. One reason for this 
obscurity is that streptococcal infections only occasionally result in 
detectable kidney damage. A possible explanation for the lack of 
consistent kidney pathology may involve the existence of nephritis 
strain-associated proteins (NSAP). Villarreal et al. ( 1979) have 
compared a number of strains of Streptococci, and determined that only 
a select few produce NSAP. These antigens are secreted by the 
organism and form immune complexes with circulating antibodies. The 
immune complexes then lodge in the kidney resulting in tissue 
necrosis. The theory that bacterial strain specific factors are 
3 
responsible for post-streptococcal sequelae is supported by Van de 
Rijn et al. (1978). These investigators demonstrated that equivalent 
levels of circulating immune complexes were found in patient 
populations suffering from two different post-streptococcal diseases, 
acute rheumatic fever (ARF) and acute post-streptococcal glom-
erulonephritis (APSGN). Villareal et al. (1979) have identified a 46 
Kd protein from bacterial strains isolated from patients diagnosed 
with post streptococcal acute glomerulonephritis. NSAP contains 
structural and biochemical properties identical to streptokinase. 
Both molecules share the first 21 amino-terminal amino acids (Johnston 
and Zabriskie, 1986). 
A second reason for sporadic glomerulonephritis following strep-
tococcal infection may be genetic susceptibility to the disorder. 
Pre-liminary studies examining the HLA type of Japanese patients 
suffering from APSGN implicate the HLA antigen DR. l as a possible 
prerequisite for the disease. APSGN as well as other 
glomerulopathies in the study seem to be associated with MHC class II 
antigens rather than MHC class I antigens (Naito et al.,1987). 
The class and subclass of anti-GBM antibody may be a third factor 
in determining those individuals who are susceptible to 
glomeruloneph-ritis (Lockwood et al., 1987). By examining the sera 
from 20 patients with anti-GBM nephritis a correlation was drawn 
between IgG subclasses and the occurrence of kidney pathology. Levels 
of IgG2 were exceedingly low, while IgG3 was not even detectable. 
IgG1 and IgG4 on the other hand, were detectable in the sera and 
eluted from the kidneys of these patients. Lockwood et al. (1987) 
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were presented with a case history of an individual whose kidney 
biopsy showed a linear deposition along the basement membrane but 
failed to follow the normal course of anti-GBM nephritis. Subclass 
analysis showed that the individual's serum anti-GBM antibody was 
exclusively IgG4. In addition to the clinical data, IgG4 antibodies 
are univalent, do not fix complement, and do not have the facility for 
binding to macrophages through the Fe receptor. IgG1 has, therefor, 
been implicated as the subclass of anti-GBM antibody responsible for 
the damage directed towards the kidney. 
APSGN is by definition associated with previous infection by 
group A, Beta hemolytic streptococci. Yoshimoto et al. (1987) 
developed 15 monoclonal antibodies to SCM, and isolated the antigen 
which bound to each monoclonal antibody. They then screened human 
serum for antibodies that would bind to these isolated antigens. Sera 
of children with APSGN were compared with sera from children with 
uncomplicated streptococcal pharyngitis, and from normal controls. 
The children with APSGN had significantly higher levels of antibodies 
to the isolated SCM (Yoshimoto et al.,1987). 
The presence of granular immune deposits in the GBM, as detected 
by fluorescent staining, seems to indicate that it is immune complexes 
which induce the glomerulonephritis. At least three theories have 
been proposed to explain the occurrence of APSGN: 1) Immune complex 
deposition in the GBM; 2) In situ formation of immune complexes and 3) 
Production of anti-streptococcal cytoplasmic membrane (SCM) antibodies 
cross-reactive with GBM epitopes. 
unclear. 
Overall the etiology of APSGN is 
5 
In the theory involving immune complex deposition, processing of 
the streptococci by the immune system produced a pool of soluble 
antigens which readily complex with their respective antibodies. 
Friedman et al. (1984) extracted immune complexes from sera of 
patients with post streptococcal sequelae they demonstrated that the 
complexes had streptococcal substituents as their antigenic component. 
Sera from rabbits receiving the immune complexes contained antibodies 
which reacted with streptococcal strains associated with either ARF or 
APSGN (Friedman et al., 1984). The circulating immune complexes (CIC) 
are trapped by the GBM while being filtered through the kidney. Once 
trapped the immune complexes initiate the activation of the complement 
cascade resulting in destruction of the GBM (Zabriskie et al., 1973; 
Rodriguez-Iturbe et al.,1980). The correlation between CIC and tissue 
pathology however, is tenuous (Yoshizawa et al., 1983). 
The more elaborate theory of in situ formation of immune 
complexes proposes that streptococcal antigens circulating within the 
vasculature are trapped by the GBM. Subsequent to this the antigens 
are complexed with anti-GBM antibodies and a complement mediated 
reaction occurs (Michael et al., 1966; Yoshizawa et al.,1973). The 
interaction between the GBM and the macromolecules antigens, 
antibodies or immune complexes) it comes in contact with occurs 
because of an over-all negative charge on the GBM. This phenomena 
results in an electrostatic repulsion of anionic macromolecules and an 
attraction of cationic macromolecules. While neutral or negative 
charged molecules, -68Kd in size (about the size of albumin), enter 
the GBM in very small numbers (Farquhar, 1978), highly cationic macro-
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molecules can penetrate into all three layers of the GBM (Rennke et 
al., 1975). Rather than an immune complex being deposited into the 
GBM, Vogt (1984) suggested that cationic macromolecules (57Kd or 
greater) enter the GBM, and the immune complex arises in situ. 
support of in situ immune complex formation was provided by Stinson et 
al. (1984) who absorbed discreet antigens from extracts of~- mutans 
MT703 with rabbit and monkey kidney homogenates. Intact cells of~-
mutans were extracted sequentially with a combination of organic 
solvents and ammonium hydroxide. After incubation, the bacterial 
extracts which bound to the homogenated kidneys were eluted and loaded 
on to acrylamide gels.~- mutans antigens of 65Kd, 35Kd, and 24Kd were 
isolated by SOS-PAGE. Immune complexes with a net positive (cationic) 
charge also have the capacity to permeate the various layers of the 
GBM (Caulin-Glaser et al., 1983). 
While the above mentioned theories propose the interaction of 
antibody and foreign antigen, the remaining theory states that 
antibodies produced in response to a challenge by streptococci cross-
react with antigens in mammalian basement membranes. This theory 
implies an epitope(s) common to mammalian basement membrane and SCM. 
If this is true an animal model of kidney pathology could be induced 
simply by injection of the appropriate anti-SCM antibody. Markowitz 
et al. (1960) demonstrated a direct relationship between the Group A 
streptococci and AGN by injection of a virulent strain of Group A, 
beta hemolytic streptococci into the peritoneal cavity of rats. After 
four weeks, rat kidneys showed extensive lesions throughout the entire 
organ. Antibodies produced in response to the bacterial antigens seem 
7 
to deposit in the kidney initiating the resulting tissue damage. 
subsequently Markowitz and Lange (1964) established that the 
immunologic foci for the induction of a cross-reactive antibody was 
the SCM. Crude extracts of streptococcal cell wall, as well as human 
lung and kidney digests, formed a common precipitation pattern when 
immuno-electrophoresed with anti-human kidney antibodies (Holm, 1967). 
A common precipitation pattern indicates that the anti-human kidney 
antibodies are reacting with epitopes in both human tissue and 
bacterial cell wall. Why do these antibodies appear in the kidney in 
the first place? Perhaps they are produced in response to foreign 
antigens (eg. SCM). The presentation of SCM to the mammalian immune 
system induces the formation of antibodies that may cross react with 
mammalian basement membrane. The array of immune responses is, 
therefore, directed at host tissue, resulting in autoimmune phenomena 
with subsequent tissue pathology. Serological cross-reactivity 
existing between group A streptococci and antigens in the GBM appear 
not to be the result of antigen deposition but rather due to 
deposition of immunoglobulins (anti-SCM antibodies) in the kidney 
which are capable of cross-reacting with the GBM. 
In support of this theory, Blue and Lange (1975) using indirect 
immunofluorescent staining procedures, demonstrated that rabbit anti-
SCM antibodies were capable of binding to human GBM. Fluoresce in 
isothio-cyanate (FITC) conjugated goat anti-rabbit gamma-globulin 
revealed a granular deposition of anti-SCM antibodies on normal human 
kidney sections. This data supports speculation regarding the cross-
reactive nature of the anti-SCM elicited antibodies. Deposition was 
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inhibited by pre-absorption of antisera with either SCM or GBM; 
homogenized liver and spleen were unable to remove the fluorescent 
pattern. Taken together, these data suggest a unique cross-reactivity 
between SCM and GBM. 
Blue and Lange (1976) went on to show that the age of the host 
played a significant role in the severity of the cross reactive 
response. Since major human GBM antigens have been shown to be 
glycoproteins, the effect of carbohydrase treatment on GBM was 
evaluated in terms of it's role in the extent of anti-SCM binding to 
GBM. Increased cross reactivity between anti-SCM antibodies and GBM 
of carbohydrase treated kidney tissue pointed to a glycoprotein as the 
cross-reactive epitope. This data was supported by previous work by 
Quish and Lange (1973) who demonstrated a greater precipitant reaction 
between SCM antiserum and GBM after treatment with a carbohydrase. 
Blue et al. (1980) confirmed, by an indirect fluorescent assay using 
rabbit anti-human GBM and FITC conjugated sheep anti-rabbit IgG, the 
role that carbohydrates play in masking GBM epitopes. Comparisons 
were made between the reactivity of anti-GBM antibodies to GBM before 
and after carbohydrase treatment of the kidney sections. Carbohydrase 
treated GBM showed greater antibody binding as indicated by greater 
fluorescence of tissue sections. Further, preabsoption of the anti-
GBM antisera with carbohydrase treated GBM reduced the ability of the 
antisera to react with the kidney sections. These studies indicated 
that a correlation existed between host age, as it is reflected in the 
level of glycosylation, and tissue antigenicity. 
The increase in the number of carbohydrate moieties that become 
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associated with proteins with increased age may mask the cross 
reactive epitope making it less reactive with SCM elicited antibodies. 
This supposition is reflected in the higher incidence of APSGN seen in 
children as opposed to adults. The relationship between glycosylation 
versus antigenicity was pursued further by Lange et al.(1981). Their 
research elucidated the role that the carbohydrate and protein 
moieties play in the immunologic cross-reactivity of the SCM and GBM. 
While the intensity of the cross-reactive response (anti-SCM 
antibodies binding to GBM) was determined by the extent of protection 
afforded by the carbohydrate, the cross-reactive moiety is in fact not 
the carbohydrate but rather it's associated protein structure. 
Antibodies directed towards the carbohydrates were only slightly 
cross-reactive with SCM while antibodies against the relevant proteins 
were extremely cross-reactive. Further, identification of the 
specific protein associated carbohydrate was achieved through the use 
of carbohydrases. Neuraminidase and Beta-Galactosidase treatment of 
normal human kidney increased the reactivity of the anti-SCM 
antibodies to the GBM. Lange et al., (1984) determined that these two 
sugars, at least in part, make up the overlying oligosaccharide side 
chain at or near the protein epitope. Anti-Heparin sulfate prote-
oglycan (HSPG) antibodies have induced subepithelial basement membrane 
thickening in the GBM (Mietinen et al., 1986). The presence of HSPG 
in the GBM, as well as the appearance of autoantibodies against HSPG 
in the sera of patients with PSAGN (Fillit et al., 1985), make this 
proteoglycan clinically significant. 
It has been suggested that specific cross-reactive antibodies 
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directed towards epitopes on both the SCM and GBM account for the sub-
epithelial humps seen in APSGN. Lange et al. ( 1985) developed an 
animal model showing that rabbit anti-SCM could stimulate synthesis of 
murine GBM. The results of this antibody treatment was a pathology 
which mim-icked PSAGN in humans (Nayyar et al. 1985a, Nayyar et al. 
1985b,Lange et al. 1985). The fact that anti-SCM antibodies raised in 
rabbit could bind to human GBM, as indicated by indirect 
immunofluorescence (Blue and Lange, 1975), supported the concept of an 
scM elicited antibody which was cross-reactive with GBM. Further 
investigations into the cross-reactive nature of anti-streptococcal 
antibodies involved the use of hybr idoma technology. Cunningham et 
al. (1984) produced hybridomas against M type 5 Streptococcus 
pyogenes, and then cloned (by limiting dilution) cells which 
synthesized anti-SCM antibodies which were cross-reactive with human 
heart antigen. ELISA (Enzyme Linked Immunosorbant Assay) and Western 
immunoblotting techniques were used by these investigators to compare 
the anti-SCM monoclonal antibodies for their reactivity to triton X-
100-extracted heart antigen. Some monoclonal antibodies cross-reacted 
primarily with heart extract while other clones reacted with similar 
epitopes ex-tracted from heart, kidney or skeletal muscle. 
Lange and Weber ( 1985) produced hybridomas from SCM immunized 
mice. Antibody production specific for SCM and GBM was detected by 
ELISA, using either trypsin or collagenase digested membrane coated 
plates. Of the fusion products tested, one polyclone (III 3C) 
produced ascitic fluid which was highly reactive with both SCM and 
GBM. From this poly-clone sixteen monoclonal antibodies have been 
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prepared which are strongly reactive with both SCM and GBM (Lange and 
weber, 1986). Gross examination of animals bearing these clones in-
traperitoneally reveals hemorrhagic lungs ranging from multiple 
patches to totally hemorrhagic lungs. Necrotic lungs appeared 
intermittently in these mice, with fe-males being more predisposed to 
tissue damage. These observations suggest that the SCM induced 
antibodies are generally reactive towards basement membrane and not 
just to GBM. Thus, the presence of anti-SCM antibody in the murine 
model appears at least on gross observation, to mimic the pathology of 
Goodpasture's syndrome (ie. lung and kidney involvement). 
However, the concept of a cross-reactive monoclonal antibody re-
sulting from "antigenic mimicry" has recently been called into 
question. Swartzwelder et al. (1988) compared reactivity of anti-
heart antibodies and anti-Streptococcal antibodies isolated from 
rabbits sensitized with Streptococcus mutans whole cell homogenate. 
These investigators first demonstrated that low levels of autoa-
ntibodies to heart antigens were endogenous to normal serum. Titers 
for heart reactive antibodies (HRA) were increased after immunization 
with~- mutans but the bacterial homogenate did not seem to induce the 
formation of new HRA. Affinity purified anti-~. mutans antibodies 
from immunized rabbits were tested for reactivity to solubilized heart 
components. Additionally, affinity purified anti-myosin antibodies, 
from the same rabbits were tested for reactivity to ~- mutans. 
Neither experiment showed antibodies reactive with the reciprocal 
antigen. Swartzwelder et al. (1988), therefore, contend that immuniz-
ing an animal with~- mutans stimulate an increase in the production 
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of naturally occurring, non-cross-reactive autoantibodies, not the 
formation of new cross-reactive antibodies. 
In disease states such as Goodpasture's syndrome and APSGN, auto-
antibodies directed against the various components of the glomerular 
basement membrane (including type IV collagen) arise and contribute to 
the pathology of these diseases. Glomerulonephritis in Goodpasture's 
syndrome may be distinguished from the nephritic state of APSGN in 
that the former disease is associated with a single linear deposition 
of antibodies along the endothelial aspect of the basement membrane 
( Schiffer et al. , 1981) • The latter condition includes granular 
deposits of immunoglobulins at this site. Case histories have been 
reported, however, of patients diagnosed with Goodpasture' s having 
both linear deposits (antiglomerular basement membrane antibodies) and 
granular deposits (immune complexes) • In addition to its 
characteristics subepithelial humps, APSGN appears to differ from 
Goodpasture's syndrome in terms of the variety of autoantibodies which 
arise in these diseases. Destruction of the kidney in APSGN may be 
traced to one or more autoantibodies. Serum from APSGN patients have 
been found to contain antibodies reactive against a number of basement 
membrane constituents, including heparin sulfate proteoglycan and 
galactose-containing proteoglycan (Fillit et al., 1984), as well as 
laminin and the 7-S fragment of type IV collagen (Kefalides et 
al., 1986). On the other hand, there seems to be a general agreement 
that serum from Goodpasture' s patients contain autoantibodies 
primarily directed at the NCl domain (Kefalides et al., 1984; 
Weislander et al., 1984; Butkowski et al., 1985; Weck et al., 1986). 
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Although these two disease states both result in glomerular damage due 
to autoantibody production, the antibodies seem to be directed toward 
different epitopes in the GBM. 
C. GOODPASTURE'S SYNDROME 
Goodpasture's syndrome has been defined classically as anti-GBM 
glomerulonephritis frequently preceded by lung hemorrhages (Wilson and 
Dixon, 1973). Circulating autoantibodies which can be detected by 
ELISA ultimately associate with the GBM and alveolar basement membrane 
(ABM). In both the GBM (Lerner et al., 1967) and ABM (Beechler et 
al., 1980; Wieslander and Heingerd, 1985) deposition of the autoan-
tibodies occurs in a linear fashion. Goodpasture's syndrome presents 
with proteinuria resulting from glomerulonephritis which progresses 
rapidly to end stage renal failure. The characteristic linear 
deposition of immunoglobulins along the GBM is primarily composed of 
IgG, and may be accompanied by IgM and IgA (Savage et al.,1986). The 
severity of pulmonary hemorrhage ranges from mild hemoptysis to severe 
respiratory failure. In addition to antibody deposition on the 
basement membrane, lung pathology is characterized by intra-alveolar 
hemorrhaging and large numbers of hemosiderin-laden macrophages 
(Beechler et al.,1980; Donald et al., 1975). The autopsied lung may 
have relatively unaffected alveoli as well as some heavily damaged 
alveoli loaded with erythrocytes, neutrophils and macrophages (Rees 
and Lockwood, 1988). A possible cause for the patchiness of lung 
damage may be reflected in the histology of alveolar capillaries in 
that alveolar capillaries are lined with unfenestrated endothelium, 
which is relatively impermeable to IgG(Bill, 1977). Jennings et al. , 
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(l981) demonstrated that increased permeability of the alveolar capil-
lary wall was necessary for the artificial induction of anti-ABM 
pneumonitis in rabbits. A number of environmental factors (i.e. 
bacterial infection and smoking) have been implicated as mediators of 
the severity of pulmonary hemorrhaging in Goodpasture's syndrome (Rees 
et al., 1977; Donaghy and Rees, 1983). Electron microscopy of lung 
biopsy show gaps between endothelial cells. These gaps contain 
platelet plugs, monocytes or processes from pneumocytes. The basement 
membranes were fragmented, irregular in outline and wider and less 
dense than normal (Donald et al.,1975). 
Genetic predisposition to Goodpasture' s syndrome is currently 
under investigation. Several investigators (Rees et al., 1978; Rees 
et al., 1984; Bernie et al., 1985) have reported a strong association 
between Goodpasture's syndrome and the histocompatibility antigen HLA-
DR2. The etiology of Goodpasture's syndrome is unknown. 
D. IMMUNOCHEMISTRY AND MOLECULAR ASPECTS 
As early as 1919 associations have been drawn between glomerulo-
nephritis and pulmonary hemorrhages (Goodpasture, 1919). Later 
Stanton and Tange ( 1958) used the term Goodpasture' s syndrome to 
identify the pathologies associated with the lung and kidney. By 
injecting human anti-GBM antibodies into monkeys Lerner et al. (1967) 
were able to induce the state of glomerulonephritis, thereby 
implicating anti-GBM antibodies as the causative agent of nephritis. 
With the recognition that Goodpasture"s syndrome tended to arise from 
an anti-glomerular basement membrane (anti-GBM) antibody, 
investigators began to restrict the use of the term Goodpasture' s 
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syndrome to patients with evidence of anti-GBM antibody formation 
(Glassock, 1978). These anti-GBM antibodies react specifically with 
basement membrane antigens of the glomerulus (Wilson and Dixon, 1979), 
alveolus (Wilson and Dixon, 1973) and renal tubules (Briggs et al., 
1979). Recently Cashman et al. (1988) were able to demonstrate the 
presence of Goodpasture' s antigen at additional sites outside the 
kidney. Antibodies eluted from kidneys of Goodpasture' s patients 
bound to basement membrane of the thyroid, eye, liver, adrenal gland, 
pituitary and breast tissue. 
The putative autoantigen(s) involved in Goodpasture's syndrome 
may be different when compared with those antigens which play a role 
in other forms of nephritis (eg. SLE and periarteritis nodosa). 
Weislander et al. (1983) exposed human GBM to a variety of chemical 
modifications. Only the antigen(s) reacting with the IgG antibodies 
present in sera from patients with Goodpasture's syndrome is sensitive 
to a reducing environment. Additional support for the unique charac-
teristics of the Goodpasture' s antigen is the fact that collagenase 
treatment of the GBM left the reactive epitope intact, while pepsin 
treatment and exposure to a reducing environment inactivated the 
epitope. These data gives some insight into the structural elements 
and location of the Goodpasture's antigen. 
The relationship between GBM and Goodpasture's syndrome has been 
reviewed by Kefalides (1987). The type IV collagen contains an alpha-
1 and an alpha-2 chain which can: l) form two distinct homotr imers 
(alpha-1)3 and (alpha-2)3 or 2) form one heterotrimer [(alpha-
1)2alpha-2] (Templet al., 1981). Type IV collagen is comprised of 
four distinct regions. They are; the collagenous domain, 
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noncollageous NC 1 and NC 2 domains, and the 7-S domain. The col-
lagenous domain is a triple helix which occupies the center of the 
type IV collagen molecule, and may be isolated from basement membrane 
by pepsin or chymotrypsin digest. The collagenous domain is flanked 
on it's carboxy side by the NC 1 domain (a globular noncollagenous 
peptide), and on it's amino side by the NC 2 domain. These domains 
are left intact during collagenase treatment but are destroyed by 
pepsin. Sodium dodecyl sulfate ( SDS)-gel electrophor-esis of the 
denatured NC 1 domain gives rise to monomeric and dimeric molecules of 
molecular weights 27Kd and 54Kd respectively. Although the 7-S domain 
is collagenous in nature, it is resistant to collagenase treatment. 
This is due to its location (the amino terminus of the molecule). 
Crosslinking of four separate type IV collagen molecules at this point 
protect the 7-S domain from collagenase digestion (Risteli et al., 
1981). 
The location of the Goodpasture• s antigen appears to be the 
globular domain NCl, a structure associated with type IV collagen at 
its carboxyl terminal end (Weislander et al., 1984; Weislander and 
Heinegard, 1985). The NCl domain is composed of a number of monomeric 
and dimeric peptides. Included among the monomers are three distinct 
peptides (Ml, M2, M3) with slightly different molecular weights in the 
range of 25 Kd to 30 Kd. Of the three monomers only one, M2 was 
reactive with sera from Goodpasture patients (Butkowski et al., 1985) 
and therefore has come to be called the Goodpasture• s antigen. M2 
sequences comprise 2.5% of the mass of type IV collagen, being located 
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in the alpha one chain. The peptide dimers exist in two classes D1 
and 02. Each of the peptide dimers in class D2 (D2a,b,c and d) 
contains the reactive epitope. Peptide mapping of these sequences 
reveals repeats of the M2 sequence (Butkowski et al., 1985). In an 
attempt to further characterize the autoantigen(s), basement membrane-
producing tumor cells were adopted. Engelbreth-Holm-Swarm ( EHS) 
sarcoma is a transplantable mouse tumor capable of producing extracel-
lular basement membrane. Wick and Templ ( 1980) demonstrated the 
capacity of this tumor to remove the relevant antibodies from 
Goodpasture sera, as indicated by a complete loss of sera reactivity 
human and murine kidney sections. Laminin, the major non-collagenous 
component of the EHS tumor, however, was by itself unable to bind the 
anti-GBM antibodies of Goodpasture sera (Weck and Templ, 1980). Wick 
et al. ( 1986) also showed that intracutaneous immunization of mice 
with the NCl domain of type IV collagen generated by the EHS tumor, 
would result in the generation of tissue reactive antibodies as 
demonstrated by ELISA and, caused kidney and lung pathology as 
indicated by immunofluorescence of tissues. 
Anti-GBM antibody binding is essential for the characterization 
of the Goodpasture's antigen(s). Holdsworth et al. (1979) used col-
lagenase solubilized antigens from human GBM to identify anti-GBM 
antibodies in sera from over 500 patients with anti-GBM diseases. 
With these anti- bodies and the antibodies eluted from 64 anti-GBM 
affected kidneys, Holdsworth et al. (1979) ran solubilized human GBM 
on 10% polyacrylamide gel electrophoresis (PAGE) and isolated 3 major 
reactive peaks (27 Kd; 53Kd and >150Kd). Human sera containing an-
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tibodies to lung basement membrane also bound to the major GBM peaks 
(Holdworth et al. 1979). Fish et al. (1984) used PAGE separation of 
collagenase digested GBM followed by Western blotting, to show that 
sera from 13 Goodpasture's patients bound to a number of the membrane 
proteins. Anti-Goodpasture' s (anti-GP) antibodies from the sera of 
these patients reacted with two protein bands in the range of 45-50 Kd 
and at least one and sometimes two or three bands in the 25-28 Kd 
range. These investigators (Fish et al. 1984) declined to speculate 
whether or not the larger molecular weight proteins represented 
repeating segments of the lower molecular weight proteins. Amino acid 
analysis of these proteins showed a low hydroxyproline, hydroxylysine 
and glycine content, suggesting that non-collagenous polar glyco-
proteins are present. The presence of cysteine indicates the presence 
of disulfide bonds (Fish et al. 1984). 
Pressey et al. (1983) prepared a monoclonal antibody to the auto-
antigenic component of human GBM using BALB/c mice immunized with a 
soluble collagenase digest of human GBM. Competitive RIA studies 
between the monoclonal antibody and anti-GBM positive human sera 
identified the probable specificity of the monoclonal antibody. The 
finding that the monoclonal antibody bound to several protein 
fractions on nitrocellulose supported the contention (Pressey et al., 
1983) that there is only one antigen which is present in multiple 
copies in the GBM. 
More recently a clinical picture of Goodpasture's syndrome has 
developed, which includes confirmed anti-GBM antibody and intermittent 
involvement of the lung. The involvement of other organs (eg skin) 
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which contain type IV collagen is also variable. While Wieslander and 
Heinegard ( 1985) were able to show the presence of the presumptive 
autoantigen(s) (26Kd and 50Kd) in basement membranes of the 
glomerulus, placenta and lung, they were unable to demonstrate 
antibody binding to intact placenta basement membrane. The presence 
of the Goodpasture' s antigen was determined by the binding of FITC-
conjugated anti-IgG antibody to the tissue indirectly through the 
anti-GP antibody, when employing the method of indirect 
immunofluorescence. The lack of antibody binding was attributed to 
either a lack of accessibility of the antigen in certain tissues, or a 
difference in the distribution of any subtype of the type IV collagen 
( subtype being the result of epitope density) (Wieslander and Hein-
gard, 1985). When the various solubilized basement membrane antigens 
were transferred from the polyacrylamide gels to nitrocellulose, 
immune staining with anti-GP antibodies showed variability of antibody 
binding. Only GBM was able to bind the antibodies with both its 26 Kd 
and 50 Kd proteins. Placenta and lung basement membrane showed 
antibody binding to the 50 Kd protein only, indicating a somewhat 
different organization of the type IV collagen from the three sources 
(Wieslander and Heingerd, 1985). 
Pusey (et al., 1987) constructed a monoclonal antibody from mouse 
B cells stimulated with collagenase-solubilized human GBM. 
Immunoblotting techniques were used to show the binding of the 
monoclonal antibody to six bands of peptides from collagenase 
solubilized GBM. The two major bands had molecular weights of 26Kd 
and 58Kd respectively. The constructed antibody was not reactive with 
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types I or II collagen, laminin, elastin, fibronectin, proteoglycans, 
double stranded DNA or single stranded DNA. The six solubilized GBM 
bands were also recognized by anti-GP antibody from Goodpasture• s 
syndrome patients. 
The development of an animal model for Goodpasture' s syndrome 
would have advantages in many aspects of the investigation of this 
disease. Using an immunologic agent which induces similar tissue 
pathology could be one means of generating an animal model. 
Autoantibodies elicited by Group A, beta hemolytic streptococcus may 
provide this pathology. 
E. ANTI-GBM ANIMAL MODELS 
In general the immune system is a highly regulated and specific 
set of responses to foreign antigens. Tolerance and/or suppression 
normally prevent the immune system from mounting a response against 
host tissue. Autoimmune diseases represent defects in the regulation 
of the immune system. Animal models are of great benefit since they 
provide insight into the break down of this highly regulated system. 
Anti-GBM animal models tend to be generated by one of two methods: l) 
foreign antigens, primarily toxic chemicals or heterologous GBM 
injected into mammalian models for the generation of anti-GBM an-
tibodies or 2) The direct in vivo addition of such anti-GBM 
antibodies. 
Druet et al., (1977) were able to induce the production of anti-
GBM antibodies in Brown Norway rats by subcutaneous injecting Mercuric 
Chloride. Anti-GBM antibody production was detected by direct 
fluorescence of kidney sections using sheep anti-rat IgG antisera. 
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Heterologous GBM has been used in numerous studies to induce the 
formation of host re-active anti-GBM antibodies (Steblay, 1962; 
steblay and Rudofsky, 1983a). Of greater significance is the fact 
that, when human LBM was injected into sheep, the animal developed 
autoantibodies directed not only to-wards their LBM but also GBM 
1983b). As early as 1956 rabbit antibodies ( steblay and Rudofsky, 
directed against the rat kidney have been used as a tool in the 
formation of animal models for the study of nephritic states (Ortega 
and Mellor, 1956). Later Lerner et al., (1967) showed that anti-GBM 
antibodies were capable of inducing nephritis in an animal model. 
To our knowledge no animal model exists for the study of Good-
pasture• s syndrome. An animal model would be of great benefit in 
addressing a number of questions regarding the nature of the disease. 
First, Goodpasture• s syndrome by nature presents with sporadic lung 
hemorrhage with a wide range of severity. While smoking, bacterial or 
viral infection have been implicated (Bentoit et al., 1964; Rees et 
al., 1977; Rees, 1983) no definitive answer for the mediator of lung 
involvement is known at present. Second, this disease has been shown 
to effect both sexes (Benoit et al., 1964; Savage, 1986); although 
questions as to the role that the sex of the individual plays in the 
severity of tissue damage is still unknown. Third, the factor (s) 
which initiate Goodpasture's disease remain unknown. This is an 
especially difficult problem to address since it remains unclear 
whether the agent in question initiates the production of auto-
antibodies or simply elevate preexisting autoantibodies which are al-
ready present in very low levels 
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F. LUNG ASSOCIATED AUTOIMMUNE PHENOMINA 
The glomerular damage induced during Goodpasture' s syndrome is 
accompanied by lung hemorrhage. The hemorrhage is presumably the typ-
ical cascade of events resulting from the binding of antibody and 
compliment to alveolar basement membrane (Koffler et al., 1969; 
Mercole and Hagadorn, 1973). Antibody eluted by acid wash from lung 
and kidney of Goodpasture's patients bound equally well to normal GBM 
as judged by indirect immunofluorescence (Hagadorn et al., 1969,) 
The fact that antibodies generated during Goodpasture's disease 
are found in linear deposition in the alveolar basement membrane 
implies a common antigen in the GBM and lung (Wieslander and Heingerd, 
1985). This concept is supported by Hagadorn and Mercole (1971) who 
injected rats with rabbit anti-rat lung serum and showed lung and 
kidney lesions resembling those of Goodpasture• s syndrome. Sade et 
al. (1984) employing soluble antigens, obtained from bovine glomerular 
basement membrane, demonstrated the induction of pulmonary hemorrhages 
in rabbits. The hemorrhages are thought to be due to binding of anti-
GBM antibodies to the lung basement membrane. These investigators, 
however, were not able to demonstrate this phenomena by immunofluor-
escence. One feature which the GBM and lung have in common is the 
presence of type IV collagen as part of their structural organization 
(Konomi et al.,1981). Although both contain type IV collagen the 
basement membrane's gas exchange in the lungs has necessitated a more 
diverse arrangement of basement membranes in the lung. The wall 
between two alveoli contains alveolar cells, capillaries and their 
basement membranes. Each wall has a thin side and a thick side. The 
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thin side is made up of the alveolar epithelium, a basement membrane 
and the capillary endothelium. The thin side morphology allows gas 
exchange to occur. The thick side contains both an alveolar basement 
membrane (ABM) and a capillary basement membrane (CBM) which separates 
the epithelium from the endo- thelium. The (ABM) is dense and amor-
phous, containing 3 to 5 nm long filaments which run perpendicular 
from the ABM lamina densa to the cell plasma membrane of the epithe-
lial and endothelial cells. The CBM is fibrillar and less compact than 
the ABM, containing only 1/5 the number of anionic binding sites. The 
ABM and CBM are in turn separated by interstitial type IV collagen and 
elastin. It is thought (Huang, 1978) that the thin side is in fact a 
unit membrane composed of both ABM and CBM in discreet but tightly 
packed layers. The alveolar wall also contains type I and Type II 
alveolar cells. Type I alveolar cells differ from type II cells in 
that type II cells have cytoplasmic processes (foot processes) which 
penetrate the ABM lamina densa and extend into the interstitium of the 
alveolar wall (Vaccaro and Brody, 1981). 
The related features of the lung and kidney include a large area 
of basement membrane in intimate contact with circulating antibodies, 
and the presence of type IV collagen as a structural component of the 
mem-brane. With these similarities in mind, it is understandable how 
diseases involving the GBM may also affect the lung; especially those 
diseases which are thought to be collagen related. When human LBM was 
injected in to sheep, the animals developed autoantibodies directed 
towards their LBM and GBM. Conversely, human GBM produced only anti-
GBM antibodies. Homologous antigen could not produce the disease in 
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sheep (Steblay and Rudofsky, 1983a and b). Apparently, there is a 
requirement for a heterologous or possibly exogenous antigen. 
While Goodpasture's syndrome seems to imply pulmonary necrosis re-
sulting from the presence of GBM directed antibodies, it must be kept 
in mind that lung hemorrhage and acute glomerulonephritis can occur in 
the absence of detectable levels of anti-GBM antibodies. Diseases 
which have pulmonary hemorrhages and glomerulonephritis as part of 
their symptoms yet lack the presence of anti-GBM antibodies include: 
systemic Lupus Erythematosus (Byrd and Trunk, 1973; Kuhn,1972); 
wegener's Granulomatoses (O'Donohue, 1974); and immune complex-
mediated glomerulonephritis (Beirne et al., 1973; Agodoa et al., 1976; 
Loughlin et al., 1978). Ekholdt et al. (1985) have reported a case 
with pulmonary infiltrates, linear deposition of immunoglobulins in 
the alveolar basement membrane as well as kidney lesions without anti-
glomerular basement membrane antibodies in the serum. These 
investigators (Ekholdt et al., 1985) believe this case to be a variant 
of Goodpasture's syndrome. The inability to detect circulating anti-
GBM antibodies has been explained in relation with the observed 
pathology, that is, all the antibody is bound at the sites of injury. 
Only after specific sites are saturated can one find free circulating 
antibody. 
Pulmonary hemorrhage in association with anti-GBM induced glomer-
ulonephritis seems to be primarily restricted to young adults (Beirne 
et al., 1977, Briggs et al., 1979, Johnson et al., 1985), although it 
has been reported in men and women older than 50 years (Savage et al., 
1986, Wilson and Dixon, 1973). Wilson and Dixon ( 1981) have even 
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noted GBM antibody-associated pulmonary hemorrhages in children less 
than 10 years old. Even though both sexes are susceptible to 
pulmonary damage, the studies reviewed seem to include a greater 
number of male subjects. The severity of the pulmonary hemorrhage can 
vary from mild hemoptysis without respiratory symptoms to severe 
respiratory failure with onset occurring very suddenly (Rees and 
Lockwood 1988). Support for antigenic similarities between the lung 
and the kidney comes from: 1) the observation that episodes of 
pulmonary hemorrhaging in patients with anti-GBM circulating 
antibodies have been halted by bilateral nephrectomy (Hal-grimson et 
al., 1971); 2) that antibodies eluted from homogenized human lung and 
isolated human glomeruli (both tissues from Goodpasture• s patients) 
bind linearly to alveolar basement membrane (ABM) and GBM as demo-
nstrated by indirect fluorescence (Koffler et al., 1969; Mc Phaul and 
Dixon, 1970); and 3) the similarity of western blots using anti-GP 
antibody and comparing collagenase digested human GBM and ABM 
(Yoshioka et al., 1988). Of equal interest is the observation that in 
these same patients, subsequent transplants of allogeneic kidneys 
appear to remain free of the nephritic state (Nowakowski et al., 
1971). This observation can not be easily explained since the 
previous data indicate that anti-GBM antibodies from Goodpasture' s 
patients reacts in vitro with GBM isolates. 
Donaghy and Rees ( 1983), examined the relationship of inhaled 
toxins (cigarette smoke) to pulmonary hemorrhaging in patients 
presenting with glomerulonephritis due to anti-GBM antibodies. Of the 
starting patient population {51}, 43 {84%} had lung hemorrhaging as 
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detected either by hemoptysis {38} or by changes in chest X-rays and 
rise in single-breath carbon-monoxide constant{S}. All 37 smokers 
(smoked cigarettes daily at the onset of their clinical illness) had 
lung hemorrhage while pulmonary hemorrhage was found in only 2 of 10 
non-smokers. The smoking history of 4 patients was unknown, while the 
remaining two cases of pulmonary hemorrhage were the result of fluid 
overload. Presumably, this difference in lung hemorrhage between 
smokers and non-smokers was not due to an increase in anti-GBM titer 
in the smoker since these titers were not significantly different 
between the two groups. In fact, no correlation seems to exist 
between the serum titer of anti-GBM antibodies and pulmonary hemor-
rhage (Lockwood et al., 1976; Rees et al., 1977). What then causes 
the difference in pulmonary pathology when comparing smokers and non-
smokers? 
It is speculated by Donaghy and Rees (1983), that lung capil-
laries which are normally relatively impermeable to IgG (Bill, 1977) 
become permeable due to the effects of cigarette smoke. The increased 
permeability makes the alveolar basement membrane (ABM) accessible to 
circulating antibodies. Alternatively, smoking may damage the ABM, 
leaving previously sequestered GBM cross reactive epitopes exposed to 
anti-GBM antibodies. Smoke altered antigenic determinants in the ABM, 
and smoke enhancement of local antibody induced inflammatory responses 
were also presented as possible mechanisms (Donaghy and Rees, 1983). 
Severity of lung hemorrhage may also be affected by bacterial 
infections. In 16 relapses of 7 patients being treated for 
Goodpasture's syndrome, bacterial infection preceded the relapse (Rees 
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~ ru:.• I 1977) • 
support for the role of increased permeability as an initiator of 
pulmonary damage was presented by Jennings et al. (1981). Goats im-
munized with rabbit ABM were bled and the gamma-globulin fraction of 
the antisera was injected into rabbits. While goat IgG was found in 
the GBM it was not found in the lungs. A linear deposit of goat IgG 
was, however, found in the ABM of 17 of 19 rabbits who had been 
injected with the anti-ABM antibody after a 62-66 hour exposure to 
100% oxygen. In the latter experiment uptake of anti-ABM was greater 
in the lungs than in the kidney. 
Autoimmune diseases represent a defect in the immune system's 
ability to distinguish self from non-self. The immune response tends 
to be directed towards specific organs (eg. rheumatic fever, APSGN) 
rather than a general systemic phenomena. The immune system appears 
to be responding to an epitope in the affected organ which is either 
not shared by other organs or is highly sequestered in unaffected 
organs. In autoimmune phenomena involving the kidney it is unclear 
whether the epitope is endogenous (eg NCl domain of type IV collagen) 
or trapped in the GBM. SCM, whose presence would be the result of a 
previous infection, may be trapped by the filtering mechanism of the 
kidney. The immunologic response that follows would be directed 
towards the foreign antigen. On the other hand, the SCM may posses an 
epitope similar enough to epitopes in the kidney to induces a cross 
reactive response. An animal model which received anti-SCM antibodies 
without prior exposure to the bacteria would be useful in addressing 
this dilemma. The original purpose of this research problem was to 
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investigate the immunochemistry of the cross-reactivity of these mAb. 
The evolution and discovery of the potent anti-LBM activity of a 
select clone changed the thrust of this investigation toward an animal 
model for Goodpasture's syndrome. 
Goodpasture's syndrome currently is described as an anti-GBM 
generated kidney pathology with lung hemorrhage. Is the severity or 
time of onset of lung damage precipitated by certain events (eg. smok-
ing), making the reactive epitope more accessible to the reactive 
antigens, or is it simply a question of genetic disposition? Klasa et 
al. ( 1988) have speculated, based on a case study, that cigarette 
smoke could have played a role in the initial onset or reoccurrence of 
Goodpasture's syndrome. Two additional points also remain unclear in 
the investigation of Goodpasture's syndrome: l) which epitope in the 
ABM or CBM is binding the anti-GBM antibody; and 2) what environmental 
stimuli is initiating the production of lung and kidney reactive an-
tibodies? We have developed an animal model which mimics Goodpastu-
re's syndrome. Proliferation of anti-SCM antibody producing clones in 
the peritoneum of mice has resulted in glomerulonephritis and pul-
monary hemorrhages. These resultant pathologies would seem to 
indicate that a previous streptococcal infection could give rise to 
Goodpasture's event. 
CHAPTER II 
MATERIALS AND METHODS 
Isolation of SCM: 
Group AM-type 12 Streptococcus pyogenes Hektoen strain was grown 
in 10 L batches of Todd-Hewitt broth in a Biokulture Fermenter (Fer-
mentation Design Allantown, Pa) at 37°c for 18 hrs. The bacteria were 
heat killed at 56°c for 1 hr. The bacteria were harvested in a 
Sharples centrifuge at full speed (a setting of 120 on the rheostat), 
washed 3 times in normal saline, weighed, and stored frozen. SCM was 
isolated by adding 1 liter of distilled water to 75g of streptococcal 
cells and placing the cell suspension in an Eppenbach Homo-Mixer 
(Gilford-Wood Co., Hudson NY) with Superbrite glass beads, type 
120-5005 (Superbrite, 3M Co., St. Paul, Mn). The cells were disrupted 
for 35 min. with an aperture of 32 on the Homo-Mixer and a setting of 
80 on the powerstat. The cell homogenate was then filtered by suction 
through a large coarse sintered glass filter. 
The homogenate was passed through a Sharples centrifuge at top 
speed. Supernatant from the Sharples spin was passed at 2-3 
ml/min. through a Sorvall KSB "Szent-Gyorgyi and Blum" Continuous Flow 
System (DuPont Co., Newton, CN), which was assembled on a Sorvall 
RC2-B centrifuge. The solution was centrifuged twice at 5,000 rpm and 
6,000 rpm, respectively, to remove residual whole cells and cell 
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walls. The solution was then centrifuged a third time at 17,000 rpm to 
pellet cell membrane. The cell membrane pellet was the washed with 
distilled water in a continuous flow centrifugation at 17,000 rpm. 
The material was then lyophilized and checked for cell wall 
contamination by quantitative rhamnose determination by the method of 
oische and Shettle (1948). Cell membrane preparations with a rhamnose 
content of less than 0. 8% were considered free from cell wall con-
tamination. 
Isolation of GBM: 
Renal cortices from human autopsy were obtained from the National 
Diabetes Research Interchange (NORI), Philadelphia, PA. Human and 
mouse glomeruli were isolated by the method of Krakower and Greenspon 
(1978). Cortices were forced through a 64u mesh screen (F.P. Smith 
Wire Cloth Co., Franklin Park, Il) with a spatula into a container 
kept on ice. Cold phosphate buffer saline (PBS) with protease 
inhibitor, pH 7.4 was added to the filtrate, which was then spun at 
2,000 RPM for 3 to 4 min. The pelleted glomeruli were resuspended in 
cold PBS. Glomeruli were then washed and purified by allowing them to 
sediment by gravity, 6 times in cold PBS which contained tannic acid 
at 1:20,000, at 30 min. per wash, removing the supernatant by suction 
each time. The purity of the resultant suspensions were evaluated by 
light microscopy. Purified GBM was obtained following the procedure 
of Carlson (1978) which employs the following sequential steps: 
Osmotic shock in distilled water containing 0.05% sodium azide 
(Mallinckrodat, St. Louis, Mo); a 3 hrs. wash with 3% Triton Xl00 
(Sigma, St. Louis, Mo); incubation for 2 hrs. with DNAse (Sigma, St. 
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Louis, Mo) (1mg/100ml lM NaCl); 4% deoxycholate (Sigma, St. Louis, Mo) 
treatment for 2hr; and final 6 washes with distilled water containing 
o.05% sodium azide. The final product is essentially pure GBM, free 
of all serum components and cellular elements as judged by both light 
and electron microscopy. 
Isolation of LBM: 
Basement membrane was isolated from murine and human lung 
(National Diabetes Research Interchange, Philadelphia, Pa.). Lungs 
from OBA mice were pushed through a 64u mesh screen, washed once with 
PBS (pH 7.4) then washed 6 times in water containing 0.05% azide to 
isolate the basement membranes (LBM). 
Solubilization of SCM, GBM, and SCM For ELISA: 
Lyophilized SCM as well as freshly isolated GBM and LBM were weighed 
and 1mg trypsin (Sigma) in PBS, pH 6.0, was added per 100mg membrane 
preparation. The preparation was rotated at 37°c for 18 hrs., centri-
fuged at 13,000g for 30 min., and the supernatant was collected. The 
supernatant was dialyzed against distilled water overnight at 4°c with 
a membrane cut off of 3,000d (Spectrapor) (Spectrum Medical Ind, Los 
Angeles, CA) and concentrated to 5-lOmg/ml (Speed-vac, Savant 
Instruments, Inc., Hickvill, NY). The concentrated digested membrane 
was stored at -20°c until used. 
Preparation of SCM, GBM and LBM ELISA Plates: 
Quantitation of the amount of digested protein was done on a 
spectrophotometer, using the Waddell equation (OD21s - OD22s) x 0.144 
= ug protein/ml Later this protein quantitation was confirmed by the 
use of a Beckman amino acid analyzer. The three digested membranes 
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were diluted to 4ug/ml with carbonate buffer (pH 9.6). Individual 
microtiter plates were sensitized with each of the digests. Each well 
of a 96 well plate received 100 ul of the digest and was incubated 
over night at room temperature. The following day 200 ul of BSA (2%) 
was added to the wells containing the digest. After 2hrs. the wells 
were washed 15 times with PBS and stored in the freezer until use. 
ELISA Screening Protocol: 
To detect antibody production an ELISA protocol was developed. A 
primary reactant (antibody or antigen) was coated to the wells of a 96 
well microtiter plate and allowed to incubate for 1 hr. The plates 
were counter sensitized with human serum albumin (HSA) (20mg/ml in 
PBS) overnight and washed with PBS ( 0. 05% Tween 20) • The secondary 
reactant (antibody or antigen) was added to the wells and incubated 
for 1 hr. After washing with PBS (0.05% Tween 20), l00ul of 
peroxidase labeled goat anti-mouse immunoglobulin (Hyclone, Logan, 
Ut.), diluted 1:6,000 in PBS (0.5% HSA) was added to each well and 
incubated for 1hr. A second PBS (0.05% tween 20) wash was followed by 
the addition of 150ul of an equal volume mix of 2, 2 '-azinodi ( 3-
ethylbenzthiazoline sulfonic acid) (Sigma, St. Louis, Mo) (0.36mM in 
0.lM Citrate buffer pH 4.1) and 0.003% H2O2 (in PBS, pH 7.4). The 
indicator developed a blue green color which was read after 20 min. at 
405nm in a microELISA scanner. 
Sensitization of Mouse Splenocytes: 
On day one, Balb/c mice (Cox Laboratory) were immunized intra-
peri-toneally with 0.1 ml of whole SCM in saline (1mg SCM/5ml) and 
intradermally with 0 .1 ml of SCM in complete Freunds adjuvant ( 1mg 
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scM/Sml adjuvant). After two weeks the mice received an IP injection 
of the SCM/saline solution, and a 0.1 ml. intramuscular injection of 
the SCM/ incomplete Freunds adjuvant solution. The animals were 
sacrificed three days following the second injection, and the blood 
was immediately collected. Formed elements were removed from the 
blood and the remaining serum was tested by ELISA for levels of anti-
scM and anti-GBM antibodies. Serum from clone baring mice was added 
(l00ul/well) to SCM and GBM coated microtiter plates and incubated for 
1hr. The remaining procedure for detection of anti-SCM and anti-GBM 
followed the standard ELISA protocol. Every two weeks for 28 weeks 
the spleens of 2 animals (with appropriate serum antibody titers) were 
used in the fusion experiments. The spleen was aseptically recovered 
for fusion. Heart, kidneys and lungs were also removed for 
histological evaluation. Control animals were immunized with either 
complete Freunds adjuvant or incomplete Freunds adjuvant without 
antigen for the production of control hybrids. 
Cell Fusion: 
The process of cell fusion was completed under sterile conditions 
following the protocol of Goding (1980). Spleens aseptically removed 
from the treated mice, were pushed through a 100 mesh sterile screen 
which was placed in a petri plate containing 10 ml of Hank's balanced 
Salt Solution (HBSS)(GIBCO, Chagrin Falls, Oh). The HBSS containing 
the single cell suspension of splenocytes was placed on top of 5 ml of 
Ficoll to separate the lymphocytes. The cell suspension was centri-
fuged for 20 min. at 1,500 rpm. Lymphocytes were removed, washed 
twice with HBSS, then centrifuged for 5 min. at 1,000 rpm. The lym-
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phocytes and P3-X63-Ag8 plasmacytoma cells (X63) were counted and 
mixed together in a ratio of 1:5 respectively. This cell suspension 
was centrifuged for 5 min. at 1,000 rpm. The resulting pellet was 
mixed gently with 0. 5 ml of Polyethyleneglycol (PEG) (Sigma, St. 
Louis, Mo) (40 % mw 6000) for 30 sec., followed by a 6-7 min. cent-
rifugation at 600 rpm. Pelleted cells were then carefully over 
layered with 5 ml. of HBSS, and 5 ml. of M alpha+ H media (GIBCO, 
chagrin Falls, Oh.; (Hybri-Sure, Dutchland Laboratories, inc. 
Denver.Pa.)) and incubated for 1 min. at room temperature. The cells 
were then gently swirled, followed by a 5 min. centrifugation at 1,000 
rpm. After removal of the supernatant the cells were over layered 
with 5 ml of M alpha+ media and incubated for 8-10 min. at room 
temperature. The cells were gently re-suspended and the volume of the 
culture was increased to 20 ml using M alpha+ H media. The cell 
suspension was then distributed into a 96 well plate ( l00ul/well) 
containing a macrophage feeder layer. Two to four plates were 
prepared for each fusion. Cells were distributed at concentrations of 
approximately 105 cells/well. Macrophages were obtained by flushing 
the peritoneal cavity of DBA mice with 10 ml of alpha+ media. Re-
covered macrophages were counted and resuspended at a concentration of 
2 to 3 x 105/ ml; 24 hrs. prior to use 50 ul were transferred to each 
well of the 96 well plate. Each plate was checked for sterility prior 
to filling with fusion cells. On each of the next three days 
following the fusion, 100 ul of supernatant was removed from each well 
and replaced with an equal volume of HAT (Hypoxanthine, Aminopterin, 
Thymidine) media(GIBCO, Chagrin Falls, Oh). After the third day the 
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plates were allowed to stand for one week and again fresh HAT media 
was added. Supernatant from those wells that showed growth of the 
hybridomas (after 3 weeks) was screened by ELISA for the presence of 
immunoglobulins. Wells with high immunoglobulin levels were then 
tested for antibody to either SCM antigens or GBM antigens using the 
ELISA method. 
ELISA screening of Hybridomas for Ig production: 
The screening of hybrids followed the method of Voller ( 1980) 
where microtiter plates (96 well) were sensitized at 1:1,300 in PBS 
with goat anti-mouse immunoglobulin (TAGO Code 4143 u+gamma+light 
chain specific-ity). Plates were counter sensitized with human serum 
albumin (HSA) (20mg/ml in PBS). Immunoglobulin production was 
detected via affinity purified peroxidase labeled goat anti-mouse Ig 
(gamma, mu+light chain) (HyClone, Logan, Ut). This was prepared at 
1:3000 in PBS containing HSA (2g/L) and Tween 20 (0.05%) (J.T. Baker 
Co., Phillipsburg, NJ), lS0ul being added to each well for 1 hr. The 
remaining procedure for detecting Ig followed the ELISA protocol. 
Those hybrids which produced a strong positive reaction (positive for 
Ig production) were tested for the presence of antibodies to both SCM 
and GBM. 
Detection of SCM and GBM Reactive Hybridomas: 
Supernatant from Ig positive hybridomas was added (l00ul/well) to 
SCM and GBM coated microtiter plates and incubated for 1hr. The 
remaining procedure for detecting SCM and GBM reactive hybridomas 
followed the standard ELISA protocol. 
Ascites Preparation: 
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ealb/c mice were injected IP with 1 ml. of pristane (2,6,10,14 
Tetra-methylpentadecane, Aldrich Chemical Company,Milwaukee Wis). on 
the morning of the seventh day of treatment the mice were injected 
with a second dose (1 ml) of pristane. In the afternoon the mice 
received 5 x 106 SCM-positive, GBM-positive hybridoma cells IP. On day 
10-12 the animals were sacrificed,at which time the ascites fluid and 
cells were drawn up into a syringe, and the heart, lungs and kidneys 
were removed for histology. A running total of ascites producers was 
kept in a log. Information included: the number of uninjected mice; 
the number of mice injected with X-63 (control); and the number of 
mice injected with cells (hybridomas). Besides the total number of 
mice, a score was kept of the number of mice that were: maintained 
until the time of sacrifice (live); and died before the time of 
sacrifice (dead). 
Limiting Dilution of Hybridomas: 
Hybridoma cells ( IIIC3) made from SCM induced lymphocytes were 
injected into a mouse. The mouse was sacrificed 10 days later, and the 
ascites fluid was checked for antibodies to SCM and GBM using the 
ELISA assay. In an attempt to isolate those hybridomas responsible for 
anti-GBM antibody production, the ascites producing cells were 
collected and diluted to a concentration of 1 cell/well. The cells 
were allowed to propagate in the wells, and the supernatant from these 
wells were tested for GBM and SCM antibody production. Cells that 
produced a positive supernatant for GBM and SCM antibody were 
dispensed in a 96 well plate at a concentration of 10 cells/well and 
allowed to propagate. Again the supernatant from these wells were 
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tested for antibody production against GBM and SCM. The cells 
producing the positive supernatant were then diluted to a con-
centration of 1 cell/well and allowed to propagate. This last step was 
carried out an additional two times. Visual scoring of each well 
confirmed actual cell content. Only wells which started with a single 
cell were labeled as cloned. 
Isotyping Monoclonal Antibodies: 
Isotyping of the cross-reactive monoclonal antibody was accomp-
lished using a kit supplied by Hyclone laboratories. Essentially the 
manufacturers directions were followed. A stock of PLATE COATING 
SOLUTION was diluted 1 to 10 using distilled water. For each 10 ml of 
diluted PLATE COATING SOLUTION, 100 ul of Goat Anti-Mouse 
Immunoglobulin was added. The contents were mixed thoroughly and 
lOOul was added to each well of a 96 well microtiter plate. The 
plates were wrapped in plastic and incubated for 24hrs. at 4°c. 
Plates which were not used immediately had their contents drained, 
were wrapped in plastic and stored in the freezer. 
Microtiter plates were washed three times with PBS containing 
0.5ml SURFACTANT per liter of buffer. Each well then received 50ul of 
PBS-SURFACTANT, followed by the addition of 50ul of the monoclonal 
antibody of interest at a dilution of 1:500. The antibody was added 
to one column of 8 wells and incubated at room temperature for one 
hour. One column of wells was incubated with normal mouse serum in 
place of our monoclonal antibody providing us with a positive Ig 
control. 
After incubation the plates were washed twice with PBS and patted 
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dry with a paper towel. Each well of the 8 well column received two 
drops of one of the TYPING ANTISERA (Rabbit Anti-Mouse IgGl, IgG2a, 
IgG2b, IgG3, IgM, IgA). Negative controls were provided by adding 
l00ul of PBS-SURFACTANT to any well that did not receive antiserum. 
The plates were incubated for one hour at room temperature. Upon 
completion of incubation, the plates were washed three times with PBS 
and patted dry with a paper towel. The wells were then incubated with 
l00ul of diluted conjugate (peroxidase labeled Goat Anti-Rabbit 
antibody diluted 1: 4000 with PBS-SURFACTANT) for one hour at room 
temperature. 
The plates were washed three times with PBS and dried. The SUB-
STRATE REAGENT (citrate buffer containing 1% urea peroxidase) was 
diluted 1 to 10 using 9.0ml of distilled water. Next, two CHROMAPHORE 
tab-lets were added to each 10ml of diluted substrate, dissolved and 
mixed thoroughly. Each well received l00ul of SUBSTRATE-chromaphore, 
and the plates were incubated at room temperature for 20 min. Isotype 
was determined by the development of a yellow, amber color in the well 
identified by the specificity of the isotype anti-serum. 
Hematoxylin and Eosin Staining of Mouse Tissue: 
Blocks of tissue were cut from the lung and kidney of normal mice 
as well as from mice baring the specific clones (X-63, IIF4, IIHl, 
IDB, IBS, IGl0, IF3, and IIC3) and stored in Sorensen"s phosphate 
buffered glutaraldehyde. The tissues were processed by placing them 
in the following solutions for 1hr each: 80% ethanol, 80% ethanol, 95% 
ethanol, 95% ethanol, 100% ethanol, 100% ethanol, toluene, toluene, 
paraffin, paraffin. Tissues were then placed in pans of melted 
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paraffin and allowed to set. Sections were cut at a thickness of 3um, 
fixed to glass slides and stained using the following procedure. 
First, the sections were washed for 5 min. in each of the following 
solutions: xylene, xylene, 100% ethanol, 100% ethanol, 95% ethanol, 
gsi ethanol, distilled water. Next, the sections were stained for 7-
10 min. in hematoxylin and rinsed in tap water for 2 min. After the 
rinse the sections were dipped 10-15 times in 1% acid alcohol and 
rinsed again in tap water for 3min. Sections were counter stained 
with 20 dips in eosin then dipped 12 times in the following solutions: 
95% ethanol, 95% ethanol, 100% ethanol, 100% ethanol. Finally the 
sections were passed through three washes of xylene for 3 min. each 
and coverslipped. Lung sections were submitted for light microscope 
evaluation. These evaluations were made in a single blind study 
employing numbers as code identification for each animal. Histologic 
evaluations were then compared with gross appearance of tissue. 
mAb Recovery from Reactive Basement Membrane: 
GBM and LBM were isolated from all animals by the method of 
Carlson et al., (1978). Recovered, purified GBM and LBM were 
extracted three times with 0.5ml glycine hydrochloride (0.02M, pH 
2.8). The extracts (containing mAb) were immediately neutralized with 
0.2 M buffered borate, pH 8.6. Eluted antibody was assayed by ELISA 
for reactivity to trypsin digested SCM and GBM. 
Morphologic Response to Monoclonal Antibody CmAb}: 
The gross effects of antibody production on the lung of clone 
bearing mice was investigated. Lung pathology was evaluated using a 
qualitative grading system (negative, +l, +2, +3, +4), based on the 
40 
amount of observable hemorrhage. Next, the effect of a specific clone 
( IIF4) on gross lung pathology was investigated. A comparison of 
pathology was based on the number of cells injected and the sex of the 
animal. Animals scheduled for injection of clones were pretreated 7 
days earlier with 1ml of pristane IP. Clone IIF4 or control X-63 
hybrids were injected IP at cell densities of 105 , 2Xl05 or 106 • Male 
and female litter mates were employed for each grouping. All animals 
were sacrificed on day 10 or 11. 
licate. 
All experiments were done in dup-
In a separate experiment, non-pristaned animals were injected IP 
with X-63 control, or mAb IIF4 ascitic fluid. Animals received the 
ascitic fluid at one of three dilutions ( Sul/g, l0ul/g or 20ul/g), 
were sacrificed at 4 hrs. and examined at the gross level for the 
extent of lung hemorrhage. Comparisons of lung damage were made with 
respect to the dose of ascitic fluid and the sex of the animal. 
A more quantitative assay for the measure of lung damage was per-
formed using X-63, mAb and normal controls. Parameters examined in-
eluded; body weight, lung weight, lung/body (L/B) ratios and gross 
lung pathology. Cells were injected IP and mice were sacrificed on 
day 10. L/B ratios were then graded based on a table which 
arbitrarily divided the range of L/B ratios into five groups (<0.008; 
o.ooa1-o.01; 0.011-0.013; 0.0131-0.016;>0.016). 
Quantitation of Ascites IgM levels: 
Each 96 well microtiter plate was coated with goat anti-mouse IgM 
(0.lug/ml) and blocked with 1% HSA in PBS. The TEPC 183 IgMK ascitic 
fluid (Sigma, St. Louis, Mo) was serially diluted (l0ug/ml-
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10 ,oooug/ml) in PBS and incubated in the microtiter plate for 1 hr. 
separate wells received serial dilutions of one of the following 
ascitic fluids (l00ul/well): X63 (133-5) (1:10-1:10,000); IIHl (147-
l2) (1:5,000-1:64,000); IIF4 (115-3) (1:5,000-1:64,000); IIC4 (147-10) 
(1:5,000-1:64,000). The remaining procedure for quantitation of IgM 
levels followed the ELISA protocol. A standard curve was generated 
from the TEPC 183 dilutions. Based on the standard curve protein 
quantitation of all ascitic fluids were determined. 
cross-Reactivity of mAb: 
Ascites fluid from mice bearing one of several clones was tested 
by ELISA for reactivity to trypsin soluble murine lung basement 
membrane (LBM). Ascitic fluid from 5 B cell Hybrid clones (IE4, IIC4, 
IIF4, IC4 and IIHl) was diluted 1:2,000 with PBS (0.05% tween 20) and 
incubated (l00ul/well) in LBM coated microtiter plates for 1hr. X-63 
ascitic fluid provided a negative control. The remaining procedure 
for demonstration of the relative reactivity of several clones with 
LBM followed the standard ELISA protocol. clone IIC4 was then simul-
taneously tested for reactivity to SCM, GBM, LBM and myelin. Ascitic 
fluid from a positive immunoglobulin secreting CFA hybridoma was 
tested against these antigens as a second control for antibody 
binding. Ascitic fluid was diluted (1:2,000, 1:4,000, 1:8,000, 1:1-
6,000 and 1:32,000) in PBS (0.05% tween 20), and l00ul of each dilu-
tion was added to each of the 4 antigen coated microtiter plates. The 
plates were incubated for 1hr, then washed with PBS (0.05% tween 20). 
The remaining procedure showing the crossreactivity of IIC4 followed 
the standard ELISA protocol. 
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§.fM Inhibition of Antibody Binding: 
Ascitic fluid containing monoclonal antibody IIC4 was diluted 
1:s,000 in PBS (1% HSA) and incubated for 2hrs. at 37°c with varying 
amounts of intact SCM (0, 2.7, 8.1, 16.2 mg/ml). The mix was then 
incubated overnight at 4°c. Intact SCM was removed by centrifuging 
the mix for 10 min. at 4,000 rpm. Absorption of the monoclonal 
antibody was indicated by ELISA which was run on microtiter plates 
coated with SCM, GBM or LBM ( 4ug/ml) • Absorption of antibody with 
heat killed whole Streptococcus mutans was used as a negative control. 
Fluorescent Demonstration of Cross Reactive Ab: 
Small pieces of kidney and lung from normal mice as well as clone 
bearing mice were cut and mounted on dry ice in buttons of O.T.C. em-
bedding media (Miles Scientific, Il). Tissue sections, 2 um thick, 
were cut, placed on glass slides and fixed with cold acetone for 5 
min. After three 5 min. washes with PBS, a drop of Fluorescein 
Isothiocyanate (FITC) labeled goat anti-mouse antibody (HyClone, Ut) 
was applied to each section at the appropriate concentration and left 
to incubate for 1 hr. FITC labeled goat anti-mouse antibody was 
diluted (1:10 for kidney sections; 1:40 for lung sections) with PBS 
(pH 7.4) before being added to the tissue sections. Sections were 
washed three more times for 5 min. in PBS, and covered with p-
phenylenediamine in glycerol buffer mounting media (Johnson and 
Araujo, 1981) and a cover slip. 
Electron Microscopic Evaluation of Kidney and Lung: 
Blocks of tissue were cut from the lung and kidney of normal mice 
as well as from clone bearing mice and stored in Sorensen's phosphate 
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buffered glutaraldehyde. Before embedding, tissue blocks were washed 
over night in Millonig"s buffer to remove the glutaraldehyde. Tissue 
was then fixed with a 1% solution of osmium tetroxide in distilled 
water for 2 hrs. After a brief wash with Millonig"s buffer to remove 
the osmium, the tissues were run through a graded series (25%-100%) of 
acetone. Epon was gradually infiltrated into the tissue by placing 
the tissues into epon/acetone mixes of increasing epon concentration 
(1:3; 1:1; undiluted epon). Tissue was left in each concentration for 
24hrs. The tissues were then put into capsules containing fresh 
undiluted epon and placed in a 65°c oven for 24 hrs. Sections, 
approximately 0.06 um in thickness, were cut by glass knife, floated 
on to copper grids, and stained with a saturated solution of uranyl 
acetate in distilled water for 3 min. The grids were counterstained 
for 5 min. with Reynold's lead citrate then viewed in a Hitachi H-600 
transmission electron microscope. Electron micrographs were taken at 
17,000X and enlarged 5 times at printing. 
Ammonium Sulfate Fractionation of Ascites: 
Monoclonal antibody was isolated from ascitic fluid by two 
consecutive precipitations in a 33% solution of ammonium sulfate. The 
entire precipitation procedures was carried out at 4°c. Monoclonal 
antibodies were precipitated by slowly adding one part saturated 
ammonium sulfate to two parts ascitic fluid with constant mixing. The 
mixing was allowed to continue over night. The next day the mix was 
centrifuged, the pre-cipitated antibodies collected and redissolved in 
a volume of 0.9% NaCl equal to the original volume of ascitic fluid. 
Saturated ammonium sulfate was added in a ratio of two parts 
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redissolved antibody to one part saturated ammonium sulfate to again 
produce a 33% ammonium sulfate solution. The precipitated antibody 
was isolated by centrifugation and redissolved in 0.1 M phosphate 
buffer (pH 7.0), in a volume equal to the volume of the original 
ascitic fluid. Ammonium sulfate was removed by passing the solution 
over sephadex G25 (Pharmacia,NJ) at a flow rate of one drop every 15 
sec. The antibody was eluted with 0.lM phosphate buffer pH 7.0 and 
collected as it came off the column. Separation of the immunoglobulin 
from the ammonium sulfate was detected spectrophotometrically by 
changes in light absorption at 278nm. Purity of the antibody in the 
double precipitation procedure was verified by electrophoresis on 
cellulose acetate strips. The purified antibody was frozen until 
quantities sufficient for the production of an affinity column was 
available. Subsequent IgM purifications were performed by euglobulin 
precipitation (Garcia-Gonzalez et al., 1988) from ascites fluid and 
pooled serum of mice carrying one particular clone. Following dialy-
sis against two changes distilled water for 20 hours at 4°, the 
recovered IgM-rich precipitate was solubilized in borate buffered 
saline, pH 8.4. 
Electrophoresis of Monoclonal Antibodies: 
A Sephraphore III cellulose polyacetate electrophoresis strip 
(Gelman, Pa) was saturated with Barbital buffer (0.075M) pH 8.6. The 
strip was then blotted to remove excess buffer then inserted into a 
Beckman Micro-zone electrophoresis chamber containing Barbital buffer 
( 0 • 0 7 SM) pH 8 • 6 • Whole ascitic fluid as well as its 33% ammonium 
sulfate precipitable fraction were applied to separate sites at the 
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center of the strip (0.6ul) with a sample applicator (Beckman, Ca). 
The Micro-zone was connected to a power source (Shandon, type 2541, 
colab Products, Chicago Heights, Il) and run at a constant voltage of 
25ov for 20 min. The cellulose acetate was placed in Ponceau s dye 
for 10 min, and rinsed in two washes of 5% acetic acid. When the dye 
stopped dripping, the strip was allowed to dry. 
Activation and Coupling of Sepharose 48 
Activation of the Sepharose gel and ligand coupling followed the 
procedure of March et al.(1974). Briefly, Sepharose is washed three 
times with three volumes of distilled water, then centrifuged at 200g 
for 1 min. After the final wash an equal volume of distilled water is 
added to make the working slurry. The Sepharose slurry is added to an 
equal volume of 2M sodium carbonate and mixed thoroughly. Cyanogen 
bromide(CNBr) in acetonitrile(CH3CN) (2g CNBr per ml. of acetonitrile) 
is added to the slurry mixture with continuous vigorous mixing for 2 
min. The resulting mixture is vacuum filtered employing a coarse 
sintered-glass funnel and washed in succession with 0. lM NaHCO3 (pH 
9.5), deionized water and 0.2M NaHCO3 (pH 9.5). 
The activated Sepharose is placed in 0.2M NaHCO3 (pH 9.5) to 
which is added monoclonal antibody (lmg/ml of 0.lM PBS) in a ratio of 
1ml. antibody to 1ml packed gel. The mixture is refrigerated at 4°c 
for 20 hrs. with constant stirring. After 20 hrs. lM glycine is added 
and mixing is continued for 4 more hrs. at 4°c to neutralize unreacted 
cyanogen sites. The coupled slurry is poured into a sintered-glass 
funnel vacuum filtered and washed successively with 20 volumes of 0.lM 
sodium acetate (pH 4.0), 1 liter of 2M urea and 1 liter of 0.lM sodium 
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bicarbonate (pH 10). The concentration of Sepharose bound antibody was 
estimated by comparing absorbance of light (278nm) by the monoclonal 
antibody with absorbance of a known amount of normal mouse serum. The 
washed coupled gel was then poured into a glass chromatography column 
(Pharmacia, NJ) • 
Affinity Purification of Membrane Antigen: 
samples of the trypsin digested SCM, or lung were passed over the 
antibody coupled column, followed by a wash with 0.0SM PBS (pH 7.4) (6 
drops/min.). Column was washed to insure no further protein eluted. 
Antibody reactive constituents of the solubilized membrane were eluted 
from the column with 0.2M glycine hydrochloride (pH 2.7) and detected 
by UV spectrophotometry at 280nm. The eluted fractions were 
immediately neutralized with 6N NaOH. Collected fractions were placed 
in dialysis tubing (>3, 500 cut off) and dialyzed against distilled 
water for 72hrs. After dialysis the eluted fractions were lyophilized 
then redissolved in distilled water to a volume equal to that which 
was originally loaded on to the affinity column. Samples were frozen 
until needed. 
High Pressure Liquid Chromatography: 
A Waters (Millipore, Bedford Ma) high pressure liquid chromato-
graphic (HPLC) system fitted with a Waters I-125 column, a bonded 
silica column (7.8mmX30cm) with a protein separation range of 2,000-
80,000d,was employed for antigen fractionation. Aqueous solubilized 
proteins with acidic, neutral or mildly basic pl' s were adequately 
separated on this column. Just prior to use the column is flushed 
with HPLC methanol, followed by water and equilibrated with running 
particulate matter. 
Molecular Weight 
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All samples were centrifuged to remove 
A standard curve was prepared using the HPLC 
Marker Kit (United States Biochemical Corp., 
Cleveland, OH) , which contained lactate de-hydrogenase MW 140,000; 
enolase MW 67,000; adenylate kinase MW 32,000 and cytochrome c MW 
12,000. The samples were prepared in O.OSM Na2HP04 (pH 7.2-7.4) at a 
concentration of 40ug/ml. The injected volume was varied from 25ul to 
lOOul and the absorption sensitivities were either 0.005, 0.01 or 
0.02. The flow rate was 2ml/min and the chart speed was 2cm/min. 
values were plotted at log MW vs the retention time of the protein (in 
minutes). 
Glomerular Response to mAb Exposure: 
Cellular proliferation was investigated as an indicator of the 
response of glomeruli to the presence of mAb ( Jennings and Earle, 
1961). The cell number per glomerulus in Hand E sections of kidney 
was determined by counting the total number of nuclei in 20 glomeruli. 
An average number of cells/glomerulus was then determined. Kidneys 
were chosen from clone bearing mice as well as kidneys from control 
and X63 bearing mice. 
CHAPTER III 
RESULTS 
Immunization and Spleen Fusion 
Five non-immunized mice were selected at random and evaluated for 
serum antibodies. The maximum serum titer (OD at 405 nm in a range of 
o.020 to 0.030 OD units) was 1:5 to 1:10 for anti-SCM and 1:2 to 1:4 
for anti-GBM. This is in contrast to the 30 mice immunized with SCM, 
28 of which on their day of sacrifice showed anti-SCM titers ranging 
from 1:320 to 1:640 and anti-GBM ranging from 1:16 to 1:64 (OD at 
405nm were >0 .100 OD units). The two negative mice were essentially 
as the normal controls. Spleens from each of the 28 positive animals 
were used in the fusion procedure to develope the desired cross-
reactive hybridomas; however 27 were lost due to contamination and 
mechanical failures. Control animals immunized with complete Freunds 
adjuvant (CFA) alone showed serum responses comparable to the non-
immunized animals and provided spleens for immunoglobulin secreting 
control hybridomas. All experiments resulted from the one successful 
fusion of the splenocytes from the 28th animal. 
ELISA Screening of Hybridomas For Ig Production 
Hybridomas, resulting from the 28th fusion of anti-SCM primed B 
cells and X 63 myelomas, grew to confluence in 4 separate 96 well 
microtiter plates. All supernatants generated by these polyclonal 
hybridomas were tested for Ig production. Of the supernatant tested 
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from the fusion experiments, approximately 80% showed the presence of 
immunoglobulin secreting cells. About 20% of these cultures had cells 
which were described as high immunoglobulin secretors ( O. D. >0. 200) • 
The wells that had the highest levels of immunoglobulin were, plate 
III, column 3, row C (III3C), III4B, IV2F and IV7A as judged by ELISA. 
oetection of SCM and GBM Reactive Hybridomas 
All high immunoglobulin secreting hybridomas (O.D.>0.200) were 
propagated in 1.0ml cultures and retested for the presence of 
immunoglobulins, as well as anti-SCM and anti-GBM reactivity. Ap-
proximately 55% were positive (O.D.>0.100) for anti-SCM and about half 
of these or 25% were positive for anti-GBM reactivity. It must be 
stressed at this point that while some of the SCM positive (anti-SCM) 
hybrids were also reactive with GBM (anti-GBM), no hybrids were found 
which were positive for anti-GBM and negative for anti-SCM activity. 
None of the fusion products derived from control immunized animals 
showed elevated anti-SCM or anti-GBM reactivity, although high 
immunoglobulin secretor populations of cells were found. 
comprised about 20% of the fusion wells. 
These 
Table 1 summarizes the anti-SCM and anti-GBM titers of 
supernatant, from wells which grew the four highest immunoglobulin 
secreting hybrids. Ascitic fluid from X-63 cells did not contain 
elevated titers of anti-SCM or anti-GBM. Ascitic fluid from control 
animals, immunized with complete Freunds Adjuvant (CFA) alone (I3C), 
though containing 3-5 fold more immunoglobulins than X-63 ascitic 
fluid, was also negative for anti-SCM and anti-GBM. This result is in 
contrast with SCM immunized uncloned cells; III3C, II4B, IV2F and 
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TABLE 1 
TITRATION FOR ASSESSMENT OF Ab REACTIVITYa 
FUSION PRODUCT ANTIGEN TITER 
X-63 SCM <20 
GBM <16 
IC3b SCM <160 
GBM <160 
III3C SCM >20,480 
GBM >20,480 
III4B SCM >20,480 
GBM >20,480 
IV2F SCM 2,560 
GBM 1,280 
IV7A SCM 2,560 
GBM 1,280 
a Measured by ELISA 
b Control fusion spleen. Mouse was challenged with CFA only, no 
antigen. The highest imrnunoglobulin secreter well was harvested 
for injection into a mouse as a second negative control ascites 
producer. 
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IV7A- Polyclones II4B, IV2F and IV7 were frozen away for future 
investigation. 
IJ,.miting Dilution Analysis and Isotyping of Clones 
Polyclone II3C which met the criteria of reactivity with SCM and 
GBM underwent three limiting dilutions, resulting in the isolation of 
20 cloned cell lines. The cloned cells were labeled somewhat contrary 
to the polyclone hybrids. The monoclonal antibody producing cells 
were labeled by plate, row then column number (eg. IIHl). These 
clones were used to generate ascitic fluid. Over 300 animals 
including controls (Table 2) were employed during a one year period to 
generate the required ascitic fluid and mAb. All subsequent studies 
were performed using mice from this large population. 
Isotyping using the Hyclone laboratories kit was carried out on 
most of the antibodies produced by the clones of interest. The 
procedure was run in duplicate and results indicate that the 
predominate isotype of all generated clones was IgM (Table 3). 
Histologic Evaluation of Specific mAb 
The X-63 controls provide for an accumulation of ascitic fluid 
which contained essentially normal levels of mouse serum proteins and 
provided the negative control for ascitic fluid antibody testing 
(ELISA) and tissue pathology. Placement of hybridoma cells in some 
animals ( 6 in all) caused death due to what appeared to be and 
associated autoimmune tissue pathology (Table 2). The premature 
deaths in Experiment Group II, were animals which carried clone IIF4 
and exhibited severe lung hemorrhage. The finding that these were 
associated with one clone prompted us to review all subsequent animals 
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TABLE 2 
SUMMARY OF THE TOTAL NUMBER OF EXPERIMENTAL ANIMALS 
Experimental Normal X-63 Hybridoma Dead* total 
Group Controls controls Injected 
I 4 3 36 0 43 
II 0 11 67 2 78 
III 3 4 68 0 75 
IV 6 2 92 4 100 
Total 13 20 263 6 296 
*Animals which died between days 10 to 12 during ascites 
production. 
These animals showed sever autoimmune reactions. 
TABLE 3 
ISOTYPE AND ELISA TITERS OF GENERATED ASCITES EMPLOYED IN STUDY. 
Ascites 
Identify 
X-63 
IIF4 
IIHl 
IIFS 
IBS 
IF3 
IG8 
IF7 
IBS 
IIC4 
IDl 
IIFS 
IGlO 
IDS 
IIIC3 
Isotype* 
Mixed 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
IgM 
SCM 
~100 
64000 
32000 
64000 
64000 
32000 
64000 
32000 
64000 
64000 
64000 
64000 
64000 
32000 
128000 
Antigen Plates 
Pool Pool 
GBM 
~100 
64000 
64000 
8000 
128000 
64000 
128000 
128000 
128000 
64000 
64000 
8000 
64000 
32000 
128000 
LBM 
~100 
64000 
6000 
8000 
64000 
128000 
32000 
32000 
16000 
64000 
32000 
8000 
32000 
16000 
128000 
*Isotyping was determined on serially diluted ascites. For X-63 no 
single isotype was seen to have predominate concentration; findings 
were as for a normal serum. For hybridoma ascites IgM was only 
detectable isotype at 1:8000 and higher. 
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for lung hemorrhages. In vitro assays were employed in order to 
relate gross lung hemorrhage to tissue binding of cross-reactive 
monoclonal anti-SCM antibodies. LBM was considered the most likely 
site for an antigen shared by SCM, GBM and lung. 
Table 3 presents data on select mAbs for their reactivity to SCM, 
GBM and LBM solubilized antigens. It should be noted that the control 
ascites generated by X-63 plasmacytoma cells did not show appreciable 
reactivity to these test antigens. In contrast, mAb generated by the 
hybridomas produced strong anti-SCM binding and variable cross-
reactivity to the solubilized pooled GBM or LBM antigen. While the 
selection of cross-reactive clones was originally performed on GBM the 
subsequent testing on LBM produced these surprisingly variable resul-
ts, that is, some mAb displayed greater or lesser reactivity to LBM at 
the time the assessment was made. While IIF4, IBS and IF3 were stron-
gly reactive with trypsin digested lung, IIHl bound the antigen only 
weakly. Table 4 presents selected experiments of the 297 animals to 
indicate the range in pathology induced by the different clones. 
Evaluation of gross lung pathology indicated that clones IIF4, IGlO, 
and IF3 were able to produce dramatic lung hemorrhages. Typical gross 
pathology is seen in Fig. 1. The amount of lung pathology reflected 
in the degree of edema and hemorrhage appeared to be dependent on both 
the number of cells the animal received and the sex of the animal. A 
comparison of the lungs of the mice who received SX105 cells (two top 
lungs) with the lungs of the mice who received 1X105 cells (the bottom 
lungs) shows that while the lungs of both sets mice were edematous and 
hemorrhagic, the mice who were dosed with the larger cell number 
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TABLE 4 
BLIND STUDY OF LUNG PATHOLOGY* 
Gross Histologic* 
Animal No. Clone Evaluation Evaluation 
145-15 normal normal 
147-14 normal normal 
133-5 X-63 normal focal/normal 
115-3 IIF4 +4 hemorrhagic lesion massive hemorrhage 
139-6 IIF4 +3 hemorrhagic lesion massive hemorrhage 
147-12 IIHl normal normal 
147-13 IIHl normal normal 
105-18 IDB +1 hemorrhagic lesion focal 
115-2 IDB +1 hemorrhagic lesion focal 
105-17 IB5 +1 hemorrhagic lesion focal 
147-12 IB5 normal normal 
105-19 IGl0 +1 hemorrhagic lesion focal 
145-14 IGlO +4 hemorrhagic lesion massive hemorrhage 
133-8 IIIC3 +4 hemorrhagic lesion massive hemorrhage 
133-12 IF3 +3 hemorrhagic lesion massive hemorrhage 
* Selected tissues were submitted for light microscopic evaluation. 
These evaluations were made on a blind basis employing animal numbers 
as code identification 
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Figure 1. IIF4 clones were injected into the peritoneal cavity of 
pristane primed mice. These were lungs from litter mates, 2 males 
(left) and 2 females (right). The lungs on top were from mice 
receiving sx105 cells, and those on the bottom were from mice injected 
with lXlO 5 cells. The Ten days later the mice were sacrificed, the 
ascitic fluid removed and the cloned cells retrieved. Gross 
evaluation of the lungs showed overwhelming hemorrhage. Note that the 
lungs from the females appear larger and more hemorrhagic. 
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presented with lung which showed a greater degree of damage. A 
similar comparison was drawn by comparing lungs from male animals 
(left) with lungs from females (right). Lungs from the female mice 
seem to be traumatized by the clone generated antibodies to a greater 
extent. Both IIHl and X-63 appeared to have no effect on lung 
pathology, at least at the gross level. Hematoxylin and Eosin (Hand 
E) stained lung sections were then examined for histologic evaluation 
in a single blind study employing a number code for identification of 
the animal. Histologic and gross evaluation correlated well with 
regards to antibody induced lung damage. H and E lung sections of 
clone baring mice showed a classic inflammatory response. Lungs 
showed congestion with infiltrates of neutrophils and some monocytes 
indicating a progression from an acute to a chronic state (Fig. 2). 
An evaluation of gross lung pathology was made on all mice 
receiving generated clones (Table 5). The grading was quantitative 
(negative to +4), based on the extent of hemorrhaging noted in the 
lung tissue. An overview of lung pathology of the final 140 clone 
baring mice ( Table 5) correlated well with the H and E stained 
sections which indicate typical antibody induced lung damage. Hand E 
stained sections of corresponding kidney tissue again showed a neph-
ritic state presumably induced by the presence of clonally derived 
antibodies. 
In Vivo Results of mAb or Hybridoma Challenge 
Table 6 presents the selected results of an experiment designed 
to assess the effect of cell dose and animal sex on lung pathology. 
Again a qualitative assessment of lung pathology was made. In all, 
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Figure 2. H and E staining of a frozen lung section from a mouse 
bearing clone IIHl (top) was histologically the same as that from a 
control mouse. Lung from a mouse baring the IIF4 clone (bottom) 
showed massive hemorrhage and infiltrate into the alveolar spaces. 
The lung from a mouse bearing the IIHl clone was essentially normal. 
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TABLE 5 
EVALUATION OF GROSS LUNG PATHOLOGY 
GRADE 
ID No. No. Mice Neg. +1 +2 +3 
13 
19 
105 
111 
139 
145 
147 
149 
151 
Totals 
19 4 3 0 9 
13 4 6 0 3 
10 0 6 0 1 
8 7 0 0 1 
9 1 2 2 2 
21 3 11 0 5 
21 6 2 3 7 
20 3 8 2 7 
19 6 10 0 3 
140 34 48 7 38 
Murine lungs were graded qualitatively based on observable 
tissue damage. 
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+4 
3 
0 
3 
0 
2 
2 
3 
0 
0 
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TABLE 6 
PROPAGATION OF HYBRIDOMA CELL IN ANIMALS AND RESULTING PATHOLOGY* 
G R 0 s s 
EVALUATION 
TREATMENT SEX & AGE SACRIFICE TIME~ LUNG PATHOLOGY-
X-63 PLASMACYTOMA 
106 cells M-6 wks llD None/None 
F-6 wks llD None/None 
IIF4 HYBRIDOMA 
105 cells M-6 wks l0D ±/± 
F-6 wks 10D +2/+2 
2 x 105 cells M-6 wks lOD ±/± 
F-6 wks l0D +4/+4 
ID8 HYBRIDOMA 
105 cells M-6 wks l0D/llD +1/+1 
F-6 wks l0D/llD +2/+2 
5Xl05 cells M-6 wks l0D/llD +2/+3 
F-6 wks lOD/llD +3/+3 
106 cells M-6 wks l0D/llD +2/+2 
F-6 wks l0D/llD +4/+4 
IB5 HYBRIDOMA 
5X105 cells M-8 wks l0D/llD +/+ 
F-8 wks lOD/llD +4/+4 
106 cells M-8 wks l0D +/+ 
F-8 wks l0D +2/+2 
107 cells M-8 wks l0D +4/+4 
* Summary of two trials 
** In cases indicated second set of animals were sacrificed on Day 
11, Gross observations were not necessarily at variance to Day 
10 group 
+ observed hemorrhage may be real or due to aspirated blood 
1+ small isolated hemorrhages 
2+ many hemorrhages 
3+ all hemorrhages greater than 3 mm in diameter few clear areas 
4+ lungs totally hemorrhagic 
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forty animals were evaluated and in all cases the gross pathology seen 
in these animals was greater in the female than in the male litter 
mate. Data from selected clones was shown. Higher doses of injected 
cells induced a greater amount of lung hemorrhage than did the lower 
doses. Since ascites generated by X-63 cells or IC3 (CFA clones) did 
not produce any gross changes it is assumed that ascites per-se was 
not a factor. In animals with overt pathology the high level of mAb 
generated by the hybridoma cells made interpretation of dose dependent 
correlations somewhat equivocal. To obtain such correlations a direct 
injection of measured amounts of mAb was employed. IIF4 was selected 
and injected on a volume per body weight basis. The antibody 
concentration was determined by comparing dilutions of ascitic fluid 
to a TEPC standard curve (Fig. 3). For these experiments all animals 
(controls and experimentals) were the same age and were sacrificed 4 
hrs after an intraperitoneal injection of the mAb containing ascitic 
fluid (Table 7). These short term experiments demonstrate the 
rapidity of the uptake of antibody from the peritoneal cavity and its 
binding at the tissue site. Here too, as in Table 6, the 
concentration of mAb in the host is directly proportional to the 
observed severity of the gross pathology as illustrated in Fig. 1. 
Again we found the severity of the hemorrhages was greater in the 
female than the male. Mice injected with X-63 ascitic fluid showed no 
gross pathology. 
At the time of sacrifice the animals were examined for gross lung 
pathology. Body weight, lung weight and lung to body weight (L/B) 
ratios were recorded for a more quantitative estimate of lung 
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Figure 3. Optical densities were determined for a known 
concentration of IgM produced by TEPC mouse myeloma. IgM 
concentrations of ascitic fluid generated by mice baring appropriate 
clones was determined from this standard curve. 
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TABLE 7 
PATHOLOGY GENERATED BY THE INJECTION OF mAb INTO ANIMALS 
G R O S S 
TREATMENT 
IIF4 mAb 
5 µ1/g (24ug/g) 
10 µ1/g (48ug/g) 
20 µ1/g (96ug/g) 
IIF4 mAb 
5 µ1/g (24ug/g) 
10 µ1/g (48ug/g) 
20 µ1/g (96ug/g) 
SEX & AGE 
M-10 wks 
M-10 wks 
M-10 wks 
F-10 wks 
F-10 wks 
F-10 wks 
SACRIFICE TIME 
4 hrs. 
4 hrs. 
4 hrs. 
4 hrs. 
4 hrs. 
4 hrs. 
() - micrograms of immunoglobulin per gram body weight 
EVALUATION 
LUNG PATHOLOGY* 
± 
+ 
2+ 
3+ 
* mice injected with X-63 ascitic fluid showed no gross pathology 
1+ small isolated hemorrhages 
2+ many hemorrhages 
3+ all hemorrhages greater than 3 mm in diameter few clear areas 
(2 mice/group) 
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pathology. Again, out of forty animals, selected data is presented to 
contrast results (Table 8). Cell line IIF4 induced lung hemorrhages. 
Lung damage was also indicated by a large absolute lung weight 
(0.274g) as well as a large lung weight to body weight ratio (0.01-
19g). Note that ascites production alone does not produce any lung 
changes as shown for the X-63 cells. Correlation to ELISA data as 
well as that presented in previous Tables is maintained. The grade +2 
which indicates the amount of lung damage in the IIF4 clone bearing 
mouse, was derived from a table in which L/B ratios were divided into 
5 groups. A total of 36 mice was reviewed (Table 9). The lung/body 
weight ratios seemed to cluster around certain values. The cut off 
value for each group was arbitrarily assigned based on the clustering 
of these values. In this way a range of values was generated and a 
numerical value indicating the amount of tissue damage was assigned. 
The values listed under "Lung Pathology" and "Average Grade" in tables 
7 and 8 respectively were thus generated. 
Witebsky"s criteria provides guidelines for the investigation of 
autoimmune phenomena. Following these criteria, an attempt was made 
to recover mAb from all the target organs. Purified BM was isolated 
from lungs and kidneys and acid extracted. Extracted mAb was tested 
by ELISA for reactivity to SCM and GBM. Any dilution of antibody 
giving a reading above the standard deviation of the control wells was 
considered to have positive reactivity. IIF4 and IF3 produced titers 
in the range of 1:4 to 1:8 to SCM and GBM (Table 10). Though the 
titers are low, the cross reactivity of the positive reactors is 
evident. All control extracts from X-63 or normal animals were 
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TABLE 8 
LUNG PATHOLOGY RESULTING FROM INJECTION OF 
HYBRIDOMA CELLS INTO MICE 
Cell Body Lung Gross Lung 1 ... Ll:!.* * Average 
Grade-
line weight pathology* weight 
Normal 32 pink 0.1668 0.0052 
0.0066-
30 pink 0.2403 0.0079 
X-63 21.5 clear 0.158 0.0074 
0.0072 N 
X-63 21.5 clear 0.149 0.0069 
IIF4 23.0 hemorrhaged 0.2740 0. 0119 
0.0112 +2 
IIF4 23.0 hemorrhaged 0.2411 0.0105 
* Confirmed by EM and/or fluorescent microscopy. 
** Lung wt/body wt ratio 
Grades N; Normal, +l approx 50% wt gain, + 2 100% gain or 
greater over normal ratio. 
llfflll!i w..e fr lmii. ~ l2l::b i:J Clll7 (EiplJ ~ 
N 
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TABLE 9 
LUNG/BODY WT. RATIO 
RANGE GROSS PATH. No. MICE 
< 0.008 10 
0.0081-0.01 +1 10 
0.011-0.013 +2 8 
0.014-0.016 +3 5 
> 0.016 +4 3 
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TABLE 10 
ELISA OF RECOVERED mAb IN TISSUE ELUATES 
VOL. TITER 
CLONE ORGAN SEX ELUATE SCM GBM 
IIF4 Kidney M 3.0 1:4 1:4 
Lung M 3.0 
IIF4 Kidney F 3.0 1:4 1:8 
Lung F 3.0 
IIF4 Kidney F 2.0 1:4 1:4 
Lung F 2.0 
IF3 Kidney F 3.0 1:4 1:4 
Lung F 3.0 1:4 
IF3 Kidney F 2.0 1:8 1:8 
Lung F 2.0 1.4 
negative under the same testing conditions. 
cross reactivity and Specificity of mAb 
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Several clones (IE4, IIC4, IIF4, IC4, and IIHl) were screened by 
ELISA and shown to have varying reactivity to trypsin digested murine 
lung at a dilution of 1: 2000. Ascitic fluids IIF4 and IIC4 had the 
strongest reactivities (Fig. 4). To support these observations 
ascitic fluids were run in an ELISA simultaneously testing for 
reactivity to SCM, GBM, and LBM. The monoclonal antibody in the 
ascitic fluid showed strong reactivity with the all three antigens 
(GBM, SCM and LBM) (Figs. Sa,b,c). Monoclonal antibody was run on 
ELISA plates at several dilutions ( 1: 200 to 1: 32,000) . Antibody 
binding is shown to decrease in a concentration dependent manner. The 
solubilized membranes each reacted with monoclonal antibody IIC4 at 
titers as high as 1: 25,600. The monoclonal antibody reacted weakly 
with myosin (an antigen negative control) at the lowest dilutions 
(1:1,600). Ascitic fluid from a CFA hybridoma bound minimally to the 
antigens, coated on microtiter plates, thus providing an antibody 
negative control (Fig. 6) 
In an ELISA study using the same three antigens a comparison was 
made of the reactivity of clones IIF4, IIC4, and IIHl. Since levels 
of antibody can vary from clone to clone, IgM levels were determined 
for the aliquots of ascitic fluids used in these ELISAs. The 
following levels of IgM were recorded: X-63 (58.6ug/ml); IIF4 
(4,800ug/ml); IIC4 (5,000ug/ml); IIHl (10,SOOug/ml). Titers of 
equivalent concentrations were compared and IIF4 and IIC4 showed 
similar binding to the antigens (Fig.7). While IIHl reacted strongly 
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Figure 4. An ELISA was carried out to determine the reactivity of 
mAbs IE4, IIC4, IIHl, IIF4 and IC4 to trypsin digested lung. Ascitic 
fluid was run at a single dilution ( 1: 2000). Clones IIC4 and IIF4 
were determined to be two of the strongest lung reactive clones. 
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Figure Sa,b,c. Monoclonal antibody IIC4 was tested by ELISA for 
simultaneous reactivity with SCM [\\\], GBM [xxx] and LBM [///]. IIC4 
reacted strongly with the three membrane antigens but weekly with 
myelin [x x] the control antigen. Variance in the activity of 
unstable substrates was negated by showing the results as separate 
experiments. The antibody was run in quadruplicate for each dilution. 
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Figure 6. Ascitic fluid from hybridoma IC3 (a CFA hybridoma) was 
used as a negative control for non-specific reactivity of fluid 
constituents. IC3 ascitic fluid showed no substantial binding at any 
dilution to SCM [\\\], GBM [xxx], LBM [///] or myelin [xx). 
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Figure 7. Clones IIF4 [///], IIC4 [xxx] and IIHl [\\\] were 
corrected for antibody concentration and simultaneously tested by 
ELISA for reactivity to SCM, GBM and LBM. While ascites from all 
three clone reacted with SCM and GBM with equal affinity, only IIF4 
and IIC4 reacted strongly with LBM. IIHl showed only minimal binding 
to LBM. 
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with SCM and GBM, it was only slightly reactive with LBM. This data 
support the effects of these clones observed at the gross level (Table 
4) • 
SCM Inhibition of Antibody Binding: 
Binding of IIC4 mAb to trypsin solubilized SCM, GBM and LBM 
coated microtiter plates was inhibited by premixing the IIC4 ascitic 
fluid with intact SCM (Fig. 8). A dose dependent response was 
generated by increasing the concentration of intact SCM. 
mutans did not inhibit binding of the mAb to SCM. 
Fluorescent Demonstration of Cross Reactive Antibodies: 
Whole §.. 
Fluorescent antibody tests of the kidneys of all clone baring 
animals indicated that those animals receiving clones IIF4, IIC4,and 
IIHl showed positive findings (Fig. 9). FITC-labeled goat anti-mouse 
antibody bound in a granular manner to the GBM of the glomerulus. 
While lung from IIF4 and IIC4 baring mice showed fluorescence after 
incubation with FITC-labeled antibody, lung from IIHl baring mice 
showed no fluorescence (Fig. 10). All control animals gave negative 
results under the same conditions of the experimental animals. 
Electron Microscopic Evaluation of Kidney and Lung: 
Electron micrographs of GBM from X-63 baring mice (Fig. 11) show 
a basement membrane of uniform thickness and staining intensity. Both 
IIF4 and IIHl clone baring mice had basement membranes which contained 
subepithelial humps. Subepithelial humps are a classic sign of GBM 
damage appearing as a result of post-streptococcal sequelae. Electron 
micrographs of lung tissue from IIF4 clone baring mice showed an 
uneven thickening along the basement membrane. X-63 and IIHl clones 
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Figure 8. An inhibition assay using the ELISA protocol was run to 
assess the specificity of clone IIC4 reactivity with SCM, GBM and LBM. 
IIC4 was premixed with either intact SCM from §.. pyogenes ( \ \ \) or 
intact §.. mutans [ / / /]. Reactivity of mAb IIC4 with §.. pyogenes 
removed the mAb from the ascitic fluid thus inhibiting antibody 
binding with membrane antigen. There was no significant difference 
between the antigen reactivity of IIC4 premixed with §.. mutans and 
antigen reactivity of unmixed IIC4. 
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Figure 9. Frozen sections of kidney from mice bearing clone IIC4, 
IIF4 and IIHl were tested by direct fluorescence for antibody binding. 
FITC-labeled antibody show a pattern of granular deposition of 
immunoglobulin primarily in the capillary tuft of the glomeruli. 
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Figure 10. Frozen sections of lung from mice bearing the IIF4, IIC4 
and IIHl clone were tested by direct fluorescence for antibody 
binding. Clones IIF4 and IIC4 produced antibodies which bound to LBM 
as indicated by a FITC-labeled secondary antibody. Lung from IIHl 
bearing mice showed no indication of mAb binding. 
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Figure 11. Electron micrographs of GBM from X-63 bearing mice show a 
normal basement membrane. There is no indication of antibody 
deposition on the GBM. GBM from mice bearing IIF4 or IIHl presented 
with antibody deposition in the form of subepithelial humps. 
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had no effect on the LBM characteristics at this level of detection 
(Fig. 12). 
Affinity Purification of Membrane Antigen: 
The amount of IIF4 ascitic fluid collected from two mice for 
affinity chromatography was 7ml. Ascitic fluid contains in addition 
to the mAb other serum proteins. To isolate a pure sample of antibody 
from the ascitic fluid, a double precipitation with ammonium sulfate 
was initiated. The purity of the antibody isolate was necessary for 
production of the IIF4 affinity column. Purity of the antibody iso-
late was checked by electrophoresis. After ammonium sulfate fraction-
ing, the elution procedure through G25 sephadex increased the volume 
to 30ml. The ascitic fluid was concentrated to 20ml. Optical density 
(278nm) of the ascitic fluid before mixing with activated Sepharose 
was 0.175; after 20hr. of mixing the ascitic fluid had an optical 
density of 0.080. The amount of protein bound to the Sepharose was 
estimated to be 1.4mg protein/ml packed Sepharose. A separate column 
was make for the fractionation of each of the antigens ( SCM, GBM, 
LBM). The antigen was applied at a concentration of 2mg/ml. The 
effluent was washed out with 0.0SM PBS (pH 7.4), and the bound antigen 
eluted with glycine HCl. 
Each solubilized membrane produced a characteristic plot of its 
elution profile over the monoclonal antibody ( IIF4) affinity column 
(Fig. 13). When trypsin solubilized lung was eluted two separate 
peaks were collected from the effluent. The areas under the two peaks 
appear to be almost equal, though the first peak is consistently 
higher than the second. It was established that this was a sieving 
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Figure 12. Electron micrographs of lung tissue from mice bearing 
clone IIF4 showed abnormally thick and uneven basement membranes. No 
alteration could be found in the LBM of mice bearing X-63 or clone 
IIHl. 
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Figure 13. Trypsin solubilized SCM, GBM or LBM was run over a IIF4 
affinity column. The elution profile was unique for each membrane. 
Column contained 5ml. of Sephadex 4B coupled with IIF4 mAb. The 
antigen was applied at a concentration of 2mg/ml and elution of column 
bound antigen was accomplished using glycine HCl pH 2.0. 
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phenomena of the Sepharose 4B itself because; solubilized LBM which 
was passed over activated but uncoupled Sepharose also produced the 
double peaks. The eluent produces a peak that contains an area some 
what larger than the sum of the two effluent peaks. The solubilized 
GBM and SCM were similar in that very small effluent peaks were 
produced as compared to their respective eluent peaks. The GBM eluent 
formed larger peaks than did the SCM eluent. 
High Pressure Liquid Chromatography: 
When SCM and LBM were run over the affinity column, the eluent 
and effluent were collected and passed through the HPLC column. The 
HPLC tracing of the SCM effluent (Fig. 14) shows six peaks, 
representing proteins of molecular weights 22.4Kd; 20Kd; 17Kd; 10.5Kd; 
5.8Kd and 2.2Kd respectively, as determined from the standard curve 
(Fig. 15). The IIF4 affinity column eluent appears to be enriched for 
the 10.5Kd MW fragment (Fig. 16). The presence of the 5.8kd and 2.2Kd 
peaks is significant in that it indicates that these small components 
also contain the binding epitopes. 
Cellular Proliferation of Glomeruli: 
Cellular proliferation, an indicator of glomerular damage, was 
observed in the Hand E stained kidney sections of mice carrying clo-
nes IIF4 and IIHl (Fig. 17). Each clone was injected into two mice. 
Frozen sections were cut from the kidneys of clone bearing mice, with 
approximately 5 sections cut per mouse. At least 20 glomeruli per 
section were counted. Glomeruli from mice carrying clones IIF4 and 
IIHl averaged 58 nuclei and 56 nuclei respectively compared to an 
average of 35 nuclei in the glomeruli of kidneys from non-injected 
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Figure 14. LBM effluent off a IIF4 affinity column was run through an 
HPLC column. Molecular weights were determined from a standard curve. 
A high molecular weight fraction (peak A) seemed to be the major 
constituent. 
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Figure 15. A standard curve for molecular weights was generated by 
running compounds of known molecular weight through the HPLC column 
and timing their elution speed. Standards include Lactate 
Dehydrogenase (140,000), Enolase (67,000), Adenylate Kinase (32,000) 
and Cytochrome C (12,400). 
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Figure 16. LBM eluent off a IIF4 affinity column was run through an 
HPLC column. Molecular weights were determined from a standard curve. 
A low molecular weight fraction (peak F) appears to be the major 
constituent. 
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Figure 17. The number of nuclei per glomerulus was determined. 
Clones IIHl and IIF4 induced cellular proliferation in the glomeruli 
of the kidneys from clone bearing mice. X-63 was unable to induce 
proliferation. Proliferation is an indication of immunologic damage 
to basement membrane. 
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mice. No cellular proliferation was noted in the glomeruli of control 
or X-63 bearing mice where the average was 35 nuclei/glomerulus. 
CHAPTER IV 
DISCUSSION 
Autoimmune diseases present both problems and opportunities for 
understanding the immune system and its response to foreign antigens. 
Normally functioning in a protective capacity, the immune system can 
also produce antibody which will bind host antigens. Autoimmune 
diseases are a result of this action. The initial stimulus for the 
appearance of these auto-antibodies, and their relation to the normal 
repertoire of antibodies remains unclear. Human anti-DNA antibodies 
present in systemic lupus erythematosis (SLE) appears to come from 
germ line genes (Cairns et al., 1989). These antibodies can be found 
in healthy individuals in low levels (Cairns et al., 1985) 
demonstrating that the presence of auto-antibodies as determined by in 
vitro testing is not always indicative of autoimmune disease. Also, 
the cause of the elevated levels of auto-antibodies is uncertain. 
Animal models can be of great benefit in the study of cell-cell 
interaction in autoimmune diseases, their causative factors and 
pathology. The role of gender, as well as the efficacy of treatment 
protocols can be investigated using the appropriate animal model. 
We originally generated anti-SCM hybridomas in order to 
investigate mechanisms of post-streptococcal glomerulonephritis 
associated with Group A beta hemolytic streptococcal infection. Data 
and observations presented here are consistent with the accepted 
pattern of post-streptococcal glomerulonephr i tis. Though initially 
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not the goal of this dissertation, we have developed a model which 
reproduces certain aspects of Goodpasture• s s d · yn rome using select 
anti-SCM clones. These clones produce specific mAb which cause 
pathology reflecting this syndrome. The animals exposed to these 
antibodies show pulmonary hemorrhages, glomerulonephritis as well as 
deposition of antibodies into basement membrane. The development of 
this animal model, therefore, became the focus of this thesis. 
The etiology of Goodpastures's (GP) syndrome is still obscure but 
the presentation of pulmonary hemorrhage associated with a glomerulo-
nephritis and the presence of anti-GBM antibodies in the serum, is 
well accepted (Benoit et al., 1964). The presumption that the GP 
antigen is shared by the lung and the kidney is supported by the 
following discoveries: 1) the occurrence of lung hemorrhaging in 
patients who produce anti-GBM antibodies; 2) the use of bilateral 
nephrectomy to halt this hemorrhaging; and 3) the binding of anti-GBM 
antibodies to lung section. It appears therefore that an antigenic 
relationship exists between the lungs and kidneys. We have 
demonstrated that antibodies raised against SCM can produce pathology 
similar to GP when injected into the peritoneal cavity of Balb/c mice. 
Of real significance is the fact that the inducing antibody is an 
anti-streptococcal antibody rather than a heterologous antigen. Much 
has been written about the heterogeneity of Goodpastures•s antigen but 
little is known about the inducing immunogen responsible for the anti-
GP antibody (Price and Wang 1988). A rat model for GP has been 
described wherein the challenging immunogen is bovine GBM (Sado et 
al., 1984). This study employed only female animals and was able to 
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mimic a GP, after 10 weeks, in animals receiving a high (l mg) 
challenge of antigen. Our study has a significant difference in that 
the inducing immunogen is a streptococcal antigen not a heterologous 
but related tissue antigen. Further, since the host animals only see 
or are exposed to homologous cells or antibody, we believe this repre-
sents an autoimmune induced GP with a post-streptococcal sequelae 
implication. 
At this time there is no good evidence for a post-streptococcal 
etiology for GP however the results obtained by our work with anti-SCM 
hybridomas do present an interesting parameter to this human syndrome. 
Since the causative agent for GP is unknown, any relationship between 
the eukaryotic and prokaryotic membranes may give insight to factors 
which initiate autoimmune disease. If the disease state can be 
mimicked by anti-SCM antibodies perhaps a previous streptococcal 
infection played some role in the development of this autoimmune 
disease. The deposition of antibodies has been localized to the 
basement membrane of the lung and kidney. Immunofluorescence and 
electron microscopy have shown patterns of immunoglobulin deposition 
on GBM similar to that seen in PSGN ( ie. sub-epithelial granular 
staining). Linear staining is generally seen in GP. The difference 
in antibody staining patterns may reflect the difference in the course 
of the disease induced by the hybridomas as contrasted to the natural 
development of GP. 
Rees et al.(1977) have demonstrated a relationship between inter-
current bacterial infection and relapse of the clinical symptoms of 
GP. These relapses seem to be independent of a rise in anti-GBM. 
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Therefore categorizing GP as an anti-GBM disease may be misleading. 
The extensive involvement of the kidney could merely reflect the 
greater accessability of the pertinent antigen. The pathology 
reported in GP may in part be due to "infection stimulated responses 
occurring in the presence of a pathogenic autoantibody" (Rees et al., 
1977). It is hypothesized that local bacterial infections may raise 
serum levels of tumor necrosis factor (TNF) or IL-1, resulting in a 
tissue damage far beyond the localized infection. Tomosugi et al. 
( 1989) have shown that small doses of TNF and IL-1J3 amplifies the 
severity of injury caused by subsequent injections of heterologous 
anti-GBM. Tissue damage may thus be the result of autoantibodies in 
the context of an immune response to foreign antigens. 
Swartzwelder et al. (1988) contend that antigens rn. mutans) 
stimulate the production of naturally occurring non-cross-reactive 
antibodies (anti-2. mutans and anti-HRA), but not the formation of new 
cross-reactive antibodies. In our animal model the use of a 
monoclonal antibody which binds both lung and kidney supports the 
contention that cross-reactive antibodies do exist. If Swartzwelder 
et al. (1988) are correct in their assumption, an equally fascinating 
question is; How can a single antigen (2. mutans) stimulate the expan-
sion of a population of B cells directed at an apparently unrelated 
antigen (kidney)? Between antigen presentation and effector function 
some cell must stimulate both populations of B cells. 
Although preexisting autoimmune clones, being responsible for the 
generation of some clones, have not been entirely ruled out in the 
present study, we believe that these findings represent specific 
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cross-reactions of anti-SCM to specific tissue antigens and is not 
simply proliferation of multiple organ-reactive (MOR) clones as 
described by Prabhaker et al., (1984). It should be noted that these 
investigators only looked at antibodies employing an indirect fluores-
cent antibody method. In contrast, we feel that the preparation of 
carefully selected cross-reactive hybridomas may allow for studies of 
post-streptococcal sequelae. Further, if pre-existing clones were 
present it seems likely that the control fusion (IC3) (Table 1) would 
have shown higher SCM titers. Also, while a certain fraction of SCM 
hybrids when screened by ELISA were found to be reactive with GBM, 
there were no GBM hybrids generated which were not reactive with SCM. 
If we were merely stimulating preexisting autoimmune clones it would 
seem likely that non-cross reactive anti-GBM hybridomas would have 
been detected. Selected hybridomas from the fusion of an anti-SCM B 
cell and an X-63 plasmacytoma were generated in order to draw a 
relationship between streptococcal infections and PSGN (Table 1). By 
demonstrating specific reactivity of anti-SCM antibodies with GBM 
antigen insight was gained as to the bacterial constituent which 
induced the host reactive antibody and the site of antibody induced 
tissue damage. 
While investigating the relationship of anti-SCM hybridomas and 
renal pathology, it was noted that on autopsy certain mice were 
showing profound lung pathology. Because we were using polyclones it 
was unclear whether separate clones were causing lung and kidney 
damage or a single anti-SCM clone was reacting with an epitope common 
to both organs. Only the production of monoclonal antibodies could 
resolve this question. 
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Also since pathology was occurring in two 
different organ systems, and the anti-SCM hybrids were shown to be 
reactive with GBM, it was felt that a common antigen to both systems 
would most likely be found in the basement membrane. 
The topic of cross-reactive anti-streptococcal monoclonal anti-
bodies has been the subject of other studies (Cunningham, et al., 
1983, 1984, 1986 and 1988) who evaluated the reactivity of their mAb 
by Western analysis without any in vivo workup. The immune response 
to SCM is polyclonal in nature. The process of limiting dilution 
results in the production of mAb, allowing comparison of specific 
epitopes on the SCM and mammalian tissue. The ELISA data supports our 
original hypothesis that the SCM contains unique epitopes which are 
responsible for the generation of antibodies that cross react with 
mammalian antigens. We established by direct ELISA the cross 
reactivity of several of our SCM mAb to GBM and LBM (Table 3). The 
ELISA findings from generated ascitic fluid was supported by gross 
evaluation of the lung and histologic evaluation of alveolar tissue 
(Table 4). Anti-LBM reactivity translated in vivo into hemorrhagic 
lesions of the lung. 
inflammatory response. 
The histologic study revealed a stereotypic 
Polymorphic neutrophils were present in 
response to extensive cellular damage presumably due to the binding of 
mAb to LBM. The appearance of macrophages is generally considered a 
sign of the chronic nature of the inflammatory response. As 
antibodies continue to be produced by the clones and bind to host 
tissue the macrophage plays a more prominent role in removing damaged 
tissue. 
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In addition to noting the lung pathology in some early polyclone 
bearing mice, the finding of a single clone leading to death of the 
host animal reinforced the focus of this dissertation on the 
investigation of Goodpasture' s syndrome. Consistently through the 
course of this investigation both the dose of injected clone (or mAb) 
and the sex of the animal has played a significant role in the extent 
of lung damage. A dose dependent response implies a strong cor-
relation between antibody titer and tissue pathology. Table 6 
indicates that gross pathology in the lung was not the result of 
excess peritoneal fluid accumulation but because of the antibody found 
in the fluid which is equilibrating with blood and finding its way to 
host tissue. Increasing the loading dose of cells increased the 
degree of tissue damage. Additionally, equilibration of antibodies 
between peritoneal fluid and blood was rapid enough to allow injected 
antibody to reach the lung and cause damage within 4 hrs (Table 7). 
Although the role of gender in the prevalence of GP is unclear, 
it is commonly known that the incidence and severity of certain 
autoimmune diseases is dependent on the individual's sex. Presumably 
a change in steroid level is related to this differential response. 
This may be especially pertinent in the female where hormones 
fluctuate over a large range and in a cyclic nature. These changes in 
hormone levels may expose certain relevant epitopes which may directly 
stimulate the immune system. 
The use of monoclonal antibodies has enabled us to investigate 
similarities between eukaryotic basement membranes (kidney and lung) 
and the cytoplasmic membrane of Group A, beta hemolytic streptococci. 
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The fact that anti-SCM antibodies were able to produce GP symptoms 
(i.e. hemorrhagic lungs and proteinuria) was demonstrated at the gross 
level by observing lung damage, and histologic staining with Hand E. 
The pathology demonstrated by the H and E sections support an 
inflammatory response due to the presence of the anti-SCM antibody. 
All the experiments performed as part of this thesis involved the 
placing of either hybrid cells or mAb into normal streptococcal 
antigen free host; therefore, any binding of the mAb at host tissue 
sites must be due to an immunologically related tissue antigen. 
Additionally, since many experiments were performed on litter mates, 
it is assumed that any infections agent would have equal impact on 
normal, control ( X63) , and experimental animals. Furthermore, 
administration of increasing concentrations of antibody produced 
increasing levels of mAb binding especially in the female animals 
which supports the concept of cross-reactivity and rules out antibody 
binding to prelocalized streptococcal antigen. If a localized 
streptococcal antigen were to bind the antibody, one would not expect 
to find the stoichiometry displayed in the results shown in Tables 5 
and 6. Likewise, one would expect to see similar results in both 
sexes, which is contrary to data presented in this thesis. Also, it 
is likely that a persistent localized antigen would have induced an 
immune response in the host. 
discovered in any control animal. 
No evidence along this line was 
The in vivo experiments are a parallel to those of Sade, et al., 
(1984) employing anti-bovine GBM antibodies. Indeed, most reports of 
pulmonary hemorrhages seen in experimental models are a result of 
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heterologous challenge (Steblay and Rudolfsky, 1983 a & b). This we 
feel is a major shortcoming of many of these studies. Our results 
support the concept of autoimmune phenomenon arising because of cross-
reactivity of host tissue antigens and exogenous but immunologically 
related microbial antigen, not the result of de IlQYQ anti-GBM antibody 
production. 
Deposition of immunoglobulin in the lung results in edema and 
gross hemorrhagic lesions. Initially, the amount of lung damage was 
determined by qualitative evaluation. Since this evaluation of gross 
lung damage due to the presence of mAb tends to be arbitrary in 
nature, a more quantitative approach was taken. Hemorrhages in the 
lung resulting from the reactivity of mAb with the basement membrane 
result in an altered lung weight. By generating an L/B ratio for 
clone baring mice a more quantitative evaluation of antibody induced 
damage was developed. 
One of the most unique aspects of this research was the finding 
of two different types of anti-SCM cross-reactive clones. Two clones 
(IIF4 and IIC4) are able to produce pathology in the lung and kidney; 
while one clone (IIHl) affected the kidney but left the lung 
undamaged. Since GP involves glomerulonephritis with intermittent 
lung pathology, it was thought that appearance of lung hemorrhage 
depended on the recruitment of the correct antibody. Immune responses 
against most foreign bodies ( including bacterial) is polyclonal in 
nature. The immune system recognizes a variety of epitopes and 
produces antibodies against them. Then, those clones which are most 
effective at binding and eliminating the foreign body are expanded. 
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While IIF4 and IIC4 recognize an epitope shared by SCM, GBM and LBM, 
clone IIHl binds a different epitope seen on the GBM and SCM but not 
on the LBM. Apparently, the appropriate clone must be generated to 
cause lung involvement. What conditions precipitate the generation of 
a lung reactive clone is unclear. Also, the extent to which 
individuals in a population can generate this specific clone has yet 
to be determined. The fact that Goodpasture's syndrome irregularly 
shows lung hemorrhage may be explained by the theory that only a 
restricted part of a population has the capacity to generate the 
antibody which cross-reacts with lung. In the rest of the population 
a hole may exist in their repertoire, thus preventing the generation 
of this clone. 
Witebsky"s Criteria regarding autoimmune phenomena parallel 
Koch's postulate for bacterial etiology. One criteria that must be 
fulfilled to support the contention of autoimmune disease is that the 
experimental disease must be transferred to a non-immunized animal by 
serum or by lymphoid cells. we have used both ascitic fluid and 
lymphoid cells to reproduce murine lung and kidney pathology. In 
addition, by eluting antibody off an intact membrane and demonstrating 
its reactivity to SCM and GBM by ELISA (Table 10), we were able to 
show that the mAb was able to recognize a specific epitope in the 
intricate basement membrane. In vivo binding was not simply a case of 
unusually large quantities of antibody being trapped in the membrane 
in a non-specific fashion. If it were a non-specific event, ELISA 
date would not have shown such strong antibody binding. We have shown 
that the binding to in vivo basement membrane is a specific event. 
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The ELISA using monoclonal antibody IIF4 showed strong reactivity 
with SCM, GBM and LBM. The reactivity of the monoclonal antibody with 
GBM and LBM is interesting since the B cells which were used to form 
the clone were sensitized only with SCM. The weak binding of 
monoclonal antibody IIF4 and IC3 to myosin at the low dilution 
(1:1600) indicates a small non-specific binding phenomena. This data 
was further supported by reciprocal inhibition of antibody binding. 
The cross reactive nature of the mAb IIC4 caused its removal from the 
ascitic fluid when mixed with undigested Streptococcus pyogenes SCM 
but not with~- mutans. The specificity of the adsorption of antibody 
by SCM was previously demonstrated by Blue and Lange (1975). Ascitic 
fluid from clone IIC4 was used for the inhibition assay for two 
reasons: 1) IIC4 showed a somewhat stronger binding of mAb to trypsin 
digested murine lung in the ELISA screening of SCM generated clones; 
and 2) IIC4 seemed to give similar ELISA readings when tested against 
all three antigens (SCM, GBM, and LBM). Inhibiting the binding of a 
mAb that shows high reactivity to LBM indicates that the antibody is 
recognizing a major constituent in the lung. The extent of gross lung 
damage in clone baring mice supports this contention. Similar ELISA 
readings gave a clue as to the amount of inhibitor required for 
adequate demonstration of cross-reactivity. 
The concentration of ascitic fluid in the ELISA investigations 
was stated in terms of dilutions of original aliquots. To account for 
differences in mAb production between clones IgM levels in the ascitic 
fluids was determined by generating a standard curve using TEPC 
ascitic fluid which contained known amounts of IgM. Optical densities 
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of ascitic fluid from TEPC were compared against the desired clone. 
Since IIF4 and IIC4 produced comparable amounts of IgM, the amount of 
antibody used in the ELISA studies was recorded in terms of dilution 
of original immunoglobulin level. 
Direct fluorescence of lung and kidney from mice baring the IIF4 
and IIC4 clones showed binding of antibody from the respective clone 
to the observed tissue. IIHl while producing a strong fluorescence in 
the kidney showed no binding to the murine lung. In all cases the 
fluorescence appeared to be restricted to the basement membrane. This 
last point however was difficult to assess since the brightness of 
fluorescence precludes differentiation of basement membrane from 
cytoplasmic membrane. It was for this reason that electron 
microscopic techniques were employed. The electron micrographs 
clearly indicate that pathology observed in gross evaluation, 
histologic sections, ELISA, and fluorescent studies was located in the 
basement membrane. It was not surprising that subepithelial humps 
appeared in the GBM since the clones which produced them were 
originally developed from anti-SCM B cells. Subepithelial humps are 
an indication of glomerular damage due to a previous streptococcal 
infection (Lange and Nayyar, 1987; Nayyar et al., 1985) • The lungs 
of clone IIF4 baring mice showed uneven thickening of the basement 
membrane. Whether the altered make up of these basement membranes is 
due to antigen-antibody complexes or the addition of new collagen ma-
trix is unclear at this time. Regardless, these data indicate that 
the observed gross symptoms are due to damage of specific organs in 
the same sites identified in Goodpasture's syndrome. 
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When Goodpasture' s patents show organ pathology in both kidney 
and lung it is important to determine the nature of the autoimmune 
response being directed at these elected organs. ELISA data indicates 
that the immune response is specific and directed at epitopes shared 
not only between different mammalian organs but also with SCM. we 
have shown that it is possible to isolate the common antigen of these 
membranes by binding the cross-reactive mAb to an affinity column and 
passing the trypsin digests of the membrane over the column. With the 
common epitopes isolated we may begin to investigate the 
characteristics and composition of these shared epitopes. 
Although both lung and kidney contain type IV collagen the base-
ment membrane's gas exchange in the lungs has necessitated a more 
diverse arrangement of basement membranes. The wall between two 
alveoli contains alveolar cells, capillaries and their basement 
membranes. Each wall has a thin side and a thick side. The thin side 
is made up of the alveolar epithelium, a basement membrane and the 
capillary endothelium. The thin side morphology allows gas exchange 
to occur. The thick side contains both an alveolar basement membrane 
(ABM) and a capillary basement membrane (CBM) which separates the 
epithelium from the endothelium. The (ABM) is dense and amorphous, 
containing 3 to 5 nm long filaments which run perpendicular from the 
ABM lamina densa to the cell plasma membrane of the epithelial and en-
dothelial cells. The CBM is fibrillar and less compact than the ABM, 
containing only 1/5 the number of anionic binding sites. The ABM and 
CBM are in turn separated by interstitial type IV collagen and 
elastin. It is thought (Huang, 1978) that the thin side is in fact a 
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unit membrane composed of both ABM and CBM in discreet but tightly 
packed layers. The position of interstitial collagen with respect to 
the capillaries in the lung may be significant. The occurrence of 
pulmonary hemorrhages in Goodpasture' s syndrome has been linked to 
altered permeability of the lung capillaries with respect to im-
munoglobulins. Donaghy and Rees (1983), attribute this increased per-
meability to IgG, and the subsequent exposure to normally sequestered 
antigens to inhalation of cigarette smoke. Altered anti-GBM an-
tibodies, on the other hand, is not a viable explanation for pulmonary 
hemorrhage in Goodpasture's syndrome (Lockwood et al., 1976; Rees et 
al., 1977). 
During our quest to find cross-reactive monoclonal antibodies we 
noted some interesting observations. The generation of anti-SCM 
hybrids which yielded cross-reactive mAb able to react in vitro with 
GBM antigens was an early accomplishment. When various hybrids were 
placed in animals to obtain high concentrations of mAb, it was noted 
that some animals developed severe tissue pathology. In following up 
that observation we have developed an animal model which mimics 
Goodpasture's syndrome. Proliferation of anti-SCM antibody producing 
clones in the peritoneum of mice has resulted in glomerulonephritis 
and pulmonary hemorrhages. These resultant pathologies would seem to 
indicate that a previous streptococcal infection could give rise to 
Goodpasture's events. But in general terms we have a series of mAb 
able to induce autoimmune mechanisms in the host. 
will be useful in many different studies. 
Such animal models 
SUMMARY 
Initial research 
mechanism 
was directed toward understanding the 
autoimmune of post-streptococcal glomerulonephritis. 
Hybridoma clones were prepared via the fusion of non-secreting P-X63-
Ag8 plasmacytoma cells and splenocytes derived from Balb/c mice which 
were sensitized with streptococcal cell membrane (SCM). Clones were 
selected, for simultaneous anti-SCM and anti-glomerular basement 
membrane (GBM) activity by ELISA using plates sensitized with 
solubilized membrane of trypsin digested GBM or digested SCM. Per-
tinent clones were subsequently placed in mice for greater mAb con-
tent. At the time of ascites recovery it was noted that some animals 
with select clones developed severe lung lesions. These animals 
seemed to have a pathological condition similar to that of Goodpastur-
e's syndrome an autoimmune disorder characterized by anti-GBM antibody 
induced glomerulonephritis and lung hemorrhage. The cause and predis-
posing factors of Goodpasture•s remain unknown. Group A streptococcal 
infections precede a number of tissue debilitating immunologic patho-
logies i.e. rheumatic fever and glomerulonephritis The primary 
organs for these sequelae diseases are the kidney and heart and auto-
antibodies appear to be the major cause of subsequent tissue damage. 
Goodpasture's syndrome, though never directly linked with streptococ-
cal infections, mediates its pathology through kidney reactive anti-
GBM antibodies. Animals exposed to anti-SCM mAb presented with gross 
pathologies which mimicked Goodpasture's disease. Organ damage 
included hemorrhagic lungs confirmed by increased lung/body weight 
ratios and kidneys with observable petechia. Fluorescent and electron 
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microscopy confirmed localization of mAb at these tissue sites. 
Severity of damage appears to be related to the specific anti-SCM 
clone, the dose of antibody administered, and the sex of the animal. 
Specificity of the anti-SCM clones was confirmed by reciprocal 
inhibition. The anti-SCM mAb was generated by clones demonstrated by 
ELISA to have simultaneous reactivity to trypsin digested SCM, GBM, 
and lung basement membrane (LBM). The induction of a Goodpasture's 
syndrome by anti-SCM mAb has provided: 1) a possible animal model for 
this disease; and 2) a novel concept on its induction. This concept 
being based on cross-reactivity i.e. an anti-SCM antibody reacting 
with host tissue antigen inducing an autoimmune disease. 
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